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CHAPTER I. INTRODUCTION 
Although it is generally recognized that relative to 
normal persons, the attentive and psychomotor functioning of 
chronic schizophrenic patients is impaired, there is substan-
tial disagreement as to the relative effectiveness of various 
experimental variables in modifying such performance. Two 
general classes of variables whose effects on the behavior 
of different populations, including chronic schizophrenics, 
have been extensively investigated are reinforcement and 
drugs. 
Psychological investigations of schizophrenic performance 
utilizing reinforcement variables explicitly or implicitly 
make the assumption that the impaired performance of schizo-
phrenics is intrinsic to a general motivational deficit, and 
therefore is subject to change consequent to changes in the 
motivational level due to the presence of reinforcement. A 
large number of studies have investigated the effectiveness 
of various positive and negative reinforcement parameters 
with generally inconclusive results. A review of some of the 
pertinent studies follows in a later chapter. It has to be 
emphasized, however, that due to the great variability in 
experimental procedure and the possible heterogeneous nature 
of "schizophrenia," comparisons across studies are difficult 
and have a limited value only. 
Within the last decade the relationship between drugs 
and behavior in general and that of psychotropic drugs and 
behavior in particular have received increased attention in 
the psychological literature. The great increase in knowledge 
in what became known as the discipline of "psychopharmacology" 
has been accompanied by an increased realization of the 
complexity of factors, which in inter-relationship with each 
other determine the end result of a drug's effects. For 
example, it is becoming increasingly clear that the effect 
of a given drug on a given person's behavior will depend not 
only on the age, sex, and health of the subject, but also 
on his personality, although the specific relationships are 
not yet fully understood. Experimenters are also increasingly 
cognizant of the fact that the effects of a given drug will 
vary depending on the frequency and route of administration, 
and also on such extra-drug factors as the presence or absence 
of other subjects taking the medication and the subject's 
motivation to perform the required tasks. 
A question of considerable importance in drug research 
2 
is the selectivity of a drug's action. In several published 
experiments, Mirsky and associates and Kornetsky and associates 
note that in normal adults the effects of acutely given 
chlorpromazine relative to acutely given barbiturates are 
more selective with respect to sustained attention, while 
the reverse is true for cognitive functioning, even though 
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both drugs cause impairment in performance. The results from 
several experiments bearing upon the dissociation of the 
effects of chlorpromazine and barbiturates are summarized in 
an unpublished report by Mirsky and Kornetsky. 
The clinical literature suggests that as therapeutic agents 
in schizophrenia, the phenothiazines (chlorpromazine being the 
prototype of this class of drugs) are superior to barbiturates. 
In experimental settings, however, the acute administration 
of these drugs produce similar results according to some reports 
and dissimilar results according to others, Again, as in the 
case of the previously mentioned reinforcement studies, most 
studies are sufficiently different from one another with respect 
to sampling and design that comparisons across studies can at 
best be of limited value. Since the evidence from normal per-
sons suggests that the relative effects of chlorpromazine and 
barbiturates might be quite specific to the behavior under inves-
tigation, it is of great interest to investigate whether this 
would also be true in a chronic schizophrenic population. The 
comparative evaluation of the effects of chlorpromazine and a 
barbiturate on specific behaviors has, albeit indirectly, 
neurophysiological significance, since the two drugs are found 
to act most strongly on closely related yet separate midbrain 
structures. 
A large number of studies utilizing operant conditioning 
techniques have demonstrated that drug effects are dissimilar 
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depending on the schedules of reinforcement used. In human 
subjects, the simultaneous investigation of drug and reinforce-
ment effects has received less attention. The available evidence 
indicates, however, that drug effects can be altered by the 
appropriate manipulation of incentive conditions. The results 
from several experiments on post-addicts prompted the following 
statement by Wikler: 
• • • but there can be no doubt that, regardless 
of theoretical niceties, behavior is modified by 
reinforcement . • • and that the effects of drugs 
on behavior are dependent to some extent at least 
upon the previous history of reinforcements and 
the rewarding and/or punishing conditions that 
prevail at the time and in the situation in which 
administered. (1959, p. 221) 
A theoretical formulation which parsimoniously accounts for 
diverse behavioral findings and for which there is neurophysio-
logical evidence is the activation theory. The basic psycho-
logical postulate of this theory states that there is a lawful 
relationship between the level of activation or arousal and 
performance, and that this relationship is characterized by 
an inverted U-shaped curve. On a given task, that is, perfor-
mance is optimal at a moderate level of arousal and impaired 
at low or high arousal levels. Since behavioral arousal is 
sustained by the reticular formation which, due to its wide-
spread neural connections, is subject to stimulation from 
external and internal sources, a large number of variables 
are capable of modifying a given person's level of arousal. 
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The literature suggests that the effect of reinforcement 
is to raise the level of activation while the effects of chlor-
promazine and secobarbital is to lower it. The present study 
investigates the effects of these variables on the performance 
of chronic schizophrenics. Further, it is the aim of this study 
to determine whether or not the reported selective effects of 
chlorpromazine on sustained attention in normals can be demon-
strated in chronic schizophrenics. 
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CHAPTER II. HISTORICAL SURVEY 
Experimental findings and theoretical formulations from 
several diverse areas provide the historical background for 
the present study. In the present chapter, the relevant 
literature is reviewed pertaining to activation theory, the 
effects of reinforcement upon attentive and psychomotor per-
formance of chronic schizophrenics, the localization of action 
of chlorpromazine and barbiturates, and their effect on 
attention and psychomotor performance. 
A. The Neuropsychological Dimension of Activation 
Various theoretical formulations have been employed by 
psychologiststo explain the events which intervene between 
antecedant conditions and performance and the observed per-
formance differences between different population groups, such 
as normals and schizophrenics. Although a large number of 
behavioral phenomena are explicable in terms of the more 
accepted psychological theories, they are still relatively 
circumscribed in their ability to generate precise behavioral 
predications whether in real life or in the laboratory. Among 
the many reasons for this limitation, two are outstanding: 
the large number of variables that affect behavior singly 
and in interaction, and the great difficulty in measuring and 
understanding the organismic events which mediate between 
stimuli and responses. 
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Activation theory attempts to integrate a large number 
of behavioral phenomena with recent neurophysiological findings 
in order to provide a comprehensive and parsimonious theory 
of behavior. Although the experimental literature based on 
this theory is still relatively small, it contains references 
to verified predictions which were adduced from the general 
theory. 
Activation theory, in its present form, has evolved from 
the work on generalized drive by learning theorists of the 
Hull School, from the work of the "energetics" group, and from 
EEG work. The "energetics" group (Duffy 1934, 1941, 1951, 1957) 
argued that energy mobilization is a basic component of and 
lawfully related to behavior, and that the degree of energy 
mobilization reflects a central, excitation-inhibition continuum. 
Duffy felt that physiological indices hold promise for the 
quantifiable measurement of behavior. 
A similar position was expounded by D. B. Lindsley (1951) 
who, after reviewing the behavioral studies which utilized 
electroencephalographic recordings, concluded that such diverse 
phenomena as emotional behavior, sleep-wakefulness, and certain 
behavioral abnormalities can all be explained by one concept 
which he named "activation. 11 The primary index of activation 
is degree of EEG desynchronization, which is different in 
each of the above states. This, according to Lindsley, indicates 
that such behavioral phenomena are dependent upon the activity 
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of the ascending reticular activating system. 
In the meantime, neurophysiological evidence has accumulated 
concerning the importance of the reticular formation as a 
central integrative system in behavior (Jasper, et al, 1958). 
The functional importance of the reticular formation stems 
in part from its numerous connections with other structures. 
According to Papez (1959), the reticular formation has wide-
spread connections with ascending sensory pathways and descending 
motor pathways, as well as connections with various brain 
structures including the cortex. 
The work from neurophysiology and psychology was inte-
grated by Hebb (1955) in his paper on the conceptual nervous 
system in which he elucidated the importance of the nonspecific 
effects of stimulation on activation and postulated that degree 
of arousal and excellence of performance are lawfully related. 
According to Hebb, the "nonspecific projection system" exerts 
a direct influence upon the cortex and this is instrumental 
in learning and performance. If the nonspecific projection 
system is only minimally activated, learning and performance 
will be sluggish; when the degree of activation is increased, 
there will be an optimal point for behavior efficiency, 
beyond this further activation will impair performance; and 
at very high levels of activation the disturbance characteristic 
of stress--an inability to learn and a breakdown in discrimina-
tive performance--will occur. 
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The above postulated relationship between level of arousal 
and behavioral efficiency became known as the inverted U relation-
ship and is one of the major general postulates of the activation 
theory. Since arousal, according to Hebb (1955), depends on 
exteroceptive and interoceptive stimulation, including the 
spontaneous activity of the nonspecific projection system, a 
person is always characterized by a certain degree of arousal. 
Experimental evidence in support of the inverted U 
relationship between arousal and performance is provided in 
a study by Fuster (1958). Fuster compared the performance of 
monkeys on a visual discrimination task with and without the 
simultaneous application of an electric current to the reticular 
formation via implanted electrodes. A moderate current, 
Fuster reports, improves both the speed and accuracy of per-
formance, while higher intensities have an opposite effect. 
Evidence from human experimentation is less direct than 
that provided by Fuster. Stennett (1957) studied the effects 
of several incentive conditions on the auditory tracking 
ability of normal, human subjects and took concomitant measures 
from four muscle groups and conductance from the palm. The 
low incentive condition consisted of creating the impression 
that the performance was not being recorded, and the high 
incentive condition consisted of telling the subjects that 
their performance would determine whether or not they would 
receive an electric shock or earn from $2.00 to $5.00. All 
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the peripheral measures were sensitive to the changes in the 
incentive conditions and the relationship between performance 
and arousal supported the inverted U hypothesis. Kendler 
(1959) criticized Stennett's interpretation of the obtained 
results on the grounds that a causal relationship between 
arousal and performance had not been demonstrated. Since 
both performance and arousal were functions of the instructions, 
it is equally logical to conclude that performance was a 
function of arousal or that arousal was a function of per-
formance. Although seemingly valid, Kendler's criticism 
ignores the broad psychological context within the activation 
theory is cast; namely, that mediating between the stimulus 
and response are the organismic variables, the so-called 
S-0-R formula (Woodworth and Schlosberg, 1956). Looked at in 
this way, the instructions, in Stennett's study, were part of 
the stimulus configuration which brought about a change in 
the organismic state of arousal. Physiologically, this change 
was reflected in the electromyographic and palmar conductance 
recordings; behaviorally, it was reflected in the improved 
performance on the auditory tracking task. 
Bartoshuk (1955) reports that the slope of electromyo-
graphic gradients is related to reported interest in the task, 
and to the magnitude of altered incentives. He also reports 
that the inverted U relationship holds between EMG recordings 
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and performance. According to Malmo and Davis (1956) speed 
of performance in a mirror tracing task is reliably correlated 
with EMG, heart rate, and blood pressure--all of which vary 
with different incentive conditions. 
The effect of pentobarbital on reaction time was found 
by Hill, et al, (1957) to depend on the motivational state of 
the subjects: in a group of minimally motivated subjects, 
pentobarbital impaired reaction-time performance, while in a 
group of highly motivated subjects the same drug dose improved 
reaction-time performance. Although the authors do not invoke 
the activation theory to explain their results, such findings 
illustrate the usefulness and parsimony of the activation 
theory in accounting for complex results. Activation theory 
would predict that, holding all else constant, performance 
would be relatively impaired under conditions of both minimal 
and high motivation, since the former would cause too little 
and the latter too much arousal. Therefore, when a drug such 
as pentobarbital, which depresses the level of activation, 
is administered to subjects minimally aroused, their activation 
level and performance level should be further depressed; but 
when the same drug is given to subjects too high on the 
activation continuum, their level of arousal should drop and 
their performance should improve. 
These studies illustrate that: (a) the inverted U relation-
ship between arousal and performance characterizes many types 
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of behavior including attention and speed of performance; 
(b) that the level of arousal depends on exteroceptive and 
interoceptive stimulation including incentive variables; and 
(c) that a variety of peripheral physiological indices are 
reflected in the state of activation. 
The literature contains references to other behaviors which 
have proven sensitive to changes in activation level, and to 
a wide variety of variables that affect the level of activation. 
Of particular relevance to this study are the reviews by 
D.B. Lindsley (1957, 1958) in which he summarized the experi-
mental evidence for the importance of activation upon attention 
and reaction time, and the book by Berlyne (1960) which 
evaluates the relationship between reinforcement and activation 
as well as the general status of the concept of activation in 
psychology. 
Berlyne writes: 
• . • psychologists are beginning to recognize degree of 
arousal as a dimension or continuum, as one of the 
variables that would have to be assigned a value if 
the psychological condition of a human being or higher 
animal at any particular time were to be adequately 
described. (p. 48) 
• • • it has been repeatedly demonstrated experimentally 
that negative reinforcement causes heightened arousal. 
Rewarding stimuli also heighten arousal, although 
probably less sharply. (p. 174) 
It follows from the earlier discussion and the quotation 
from Berlyne that in order to predict whether a given variable 
which is known to elevate or depress the level of activation 
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will bring about an improvement or decrement in performance, 
the subject's activation baseline has to be known. MOre 
specifically, in order to predict whether the performance 
of chronic schizophrenics--the subjects of this study--will 
improve in the presence of reinforcement and be impaired in 
the presence of the drugs, the baseline activation level of 
chronic schizophrenics has to be known. Although references 
in the literature to this specific issue are meager, it 
would seem from the clinical and experimental literature about 
schizophrenia that chronic schizophrenics are normally in a 
state of hypoactivation. Arieti (1955), for example, notes 
that all classical theories of schizophrenia agree that one 
characteristic of this disorder is a reduced responsivity to 
the physical and social environment. Experimental studies 
have consistently shown schizophrenics to be impaired relative 
to normals on a wide variety of psychological tasks (Jackson, 
1960). Chronic schizophrenics were also found to be hypo-
reactive to metabolic, autonomic, and central nervous system 
stimulation (Angyal, et ~ 1940). Hypoarousal among chronic 
schizophrenics is not, however, a uniform finding. Malmo, 
et al (1951) present evidence from their own work and from 
that of others that certain indices of activation show chronic 
schizophrenics to be as high, and at times higher than normals 
on the activation continuum. These authors conclude that the 
impaired performance of chronic schizophrenics cannot be taken 
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by itself as evidence of hypoarousal, since interfering thought 
processes are more likely to occur among chronic schizophrenics 
than among normals. They further maintain that chronic schizo-
phrenics, unlike normals, are more prone to show a dissociation 
between upurposive11 , voluntary behavior and involuntary, 
physiological activity. They illustrate this contention by 
the finding that in a pain-stress test chronic schizophrenics 
showed a higher level of muscular tension and a higher heart 
rate than did normals, but they did not press a button to 
signal pain as often as did the normals. 
The present study does not utilize physiological measure-
ments of activation, but since the same subjects will be 
tested under conditions designed to increase and decrease the 
the arousal level, the changes in performance will provide an 
estimate, albeit an indirect one, of the level of activation 
in chronic schizophrenics. 
B. The Effect of Reinforcement on the Performance of 
Chronic Schizophrenics 
The previous section reviewed some of the experimental 
findings indicating that incentive conditions raise the level 
of arousal and consequently affect performance. It was also 
emphasized that the effects of incentive conditions on per-
formance depend on the pre-experimental arousal level of the 
subjects and the strength of the incentive condition. The 
studies so far reviewed used normal, human adults as their 
subjects and were mostly designed within the framework of 
activation theory. 
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The present section will review the literature pertinent 
to the effect of reinforcement upon the performance of chronic 
schizophrenics; and especially, performance on tasks similar 
to the ones utilized in the present study. The most common 
theoretical position taken by experimenters in this area has 
been that the impaired performance of chronic schizophrenics 
is due to a motivational deficit which may be corrected at 
least partially by the administration of reinforcement. The 
controversial findings are usually analyzed within such a frame-
work, and references to activation theory are very few. 
There is general agreement that relative to normals, 
chronic schizophrenics are impaired on attention and psychomotor 
tasks. There is disagreement, however, about the modifying 
effects of reinforcement on this impairment. The experimental 
literature does not contain references to studies which have 
investigated the effects of reinforcement on tasks of sustained 
attention and response latency specifically. Most relevant 
to response latency are studies of reaction time. Reaction 
time studies, however, which utilize preparatory intervals, 
test not only reaction time but also the ability to maintain 
attention. 
The effects of preparatory intervals upon reaction time 
were explored three decades ago by Huston, et al, (1937). 
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These authors found that not only were schizophrenics slower 
than normals on both simple and complex reaction time measures, 
but the magnitude of the difference between the two populations 
increased when a preparatory interval was introduced, i.e., 
a warning stimulus preceding the stimulus to which the subjects 
were required to respond. The same results were obtained by 
Rodnick and Shakow (1940), who on the basis of these findings, 
constructed a measure which they called the "set index" and 
which differentiated schizophrenics from normals without overlap. 
Some ten years later in a discussion of the various psycho-
logical defects in schizophrenia, Shakow elaborated on the 
"set index" concept: 
An examination of these varieties of conduct reveals 
that in one respect they appear to involve one or 
another aspect of expression of a single but complex 
type of difficulty: namely, the inability to keep 
a major set. By this I mean the inability to main-
tain a state of readiness to respond to a coming 
stimulus, a state which facilitates the particular 
type of activity called for. (1950, p. 384) 
Shakow's explanation of set as 11 a state of readiness to 
respond" is indeed similar to Berlyne's (1951) definition of 
attention as the "momentary effective reaction potential of 
the perceptual responsell, and to Dember and Earl's definition 
of attention as "any behavior, motor or perceptual, which has as 
its end state contact between the organism and selected 
portions of its environment" (1957, p. 91). 
In reviewing the subject, Winder states: ''simple reaction 
time is quite clearly slower and more variable among schizophrenics 
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than among normals. The defect is more pronounced if the reaction 
time procedure is made more demanding of continuous attention 
and effort" (1960, p. 206). 
According to Jenkins (1950), the withdrawal from and 
inattention to social and physical stimuli as seen in schizo-
phrenia is the outcome of prolonged frustration beyond tolerance 
in the interpersonal relationships of the people who become 
schizophrenics. He maintains that impaired schizophrenic 
functioning is reversible through an increase in motivation, 
and makes the specific prediction that positive reinforcement 
will bring about an improvement in the performance of schizo-
phrenics on a given task in which they are ordinarily found 
to perform less well than normals. 
In the case of subjects below the level of arousal optimal 
for best performance, an analogous prediction would derive from 
Berlyne's statement that "It has been repeatedly demonstrated 
experimentally that negative reinforcement causes heightened 
'arousal'. Rewarding stimuli also heighten arousal, although 
probably less sharply. . • 11 (1960, p. 174). 
A comprehensive critical review of the relationship 
between reinforcement and performance in schizophrenia was 
presented by Rodnick and Garmezy (1957) at the Nebraska 
symposium on motivation. They presented evidence that negative 
symbolic reinforcement which cannot be avoided, i.e., the 
word "wrong", has a deleterious effect upon schizophrenic 
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performance, and that positive reinforcement has a beneficial 
effect. They have also shown that the degree of vulnerability 
to negative reinforcement is correlated with the patient's 
premorbid adjustment. 
The results of extensive experimentation in this area is 
summarized in a monograph by King (1954). King compared the 
performance of several populations on a variety of psychomotor 
tasks, and on the basis of the results concluded that there 
is a high and positive correlation between severity of illness 
and degree of psychomotor impairment. Not only were schizo-
phrenics more impaired than pseudoneurotic schizophrenics, who 
were in turn more impaired than neurotics and normals, but 
within the schizophrenic group itself there were gradations 
of impairment linearly related to clinical status. 
In these studies, King did not employ reinforcement pro-
cedures, but the fact that there was a linear relationship 
between performance and degree of pathology and that the 
learning curves of the different populations were similar 
argues, King feels, against the hypothesis that increased 
motivation would tend to equate the performance levels of the 
schizophrenics and normals. 
Stotsky (1957) repeated some of King's (1954) studies in 
order to test his contention that psychomotor impairment is 
primary in schizophrenia. He tested schizophrenics and normals 
under control conditions and under conditions of positive 
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verbal reinforcement that consisted of praise and encouragement. 
There were two schizophrenic groups: a regressed group and 
a relatively intact, or remitted group. The task consisted 
of having each subject hold a finger of his right hand on a 
finger rest, and use the same finger to depress a telegraph 
key 10.5 inches to the right or left depending on whether the 
signal was a buzzer of a bell. The buzzer and bell were 
preceded by a ready signal from one to four seconds. The 
results of the study showed the normals to be superior to the 
schizophrenics, and the remitted patients to be superior to 
the regressed under control conditions. Under reinforcement 
both normals and patients improved, the greatest improvement 
occurring in the regressed patients' group. Although under 
reinforcement the difference between the two groups diminished, 
the normals were still faster. Stotsky feels that this last 
finding could be interpreted to mean that schizophrenics need 
a greater number of reinforcements. He agrees, however, that 
his results as they stand could not account for the schizo-
phrenic impairment in motivational terms alone. 
Results similar to those of Stotsky are reported by Benton, 
et al (1960). In this study there was a significant improve-
ment in the schizophrenic group when they were retested under 
11urging-to-do-better" conditions. But there was a similar 
improvement in the normals, so that the discrepancy in favor 
of the normals under standard conditions did not appreciably 
change. 
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Cohen (1956) used electric shock as the experimental 
technique for increasing motivation and compared its effects 
in normals and schizophrenics on complex reaction time tasks. 
The results were inconclusive. On some tasks the patients 
improved significantly relative to the normals, on others 
they did not. 
Rosenbaum, et al (1957a, 1957b) also used avoidance of 
electric shock as a reinforcer. In this study, the variability 
and the reaction time of the schizophrenics decreased under 
the experimental conditions. However, while the decreased 
variability was statistically significant, the decreased 
reaction time was not. The performance of the normals also 
improved, but to a lesser extent. Among the schizophrenics, 
the females and older subjects improved less, while the more 
intact patients performed at a level comparable to that of the 
normals. 
Cavanaugh (1958) investigated the effects of white noise 
on the reaction time performance of normals and schizophrenics. 
He reports that the schizophrenics improved under the experi-
mental conditions, and that this improvement made their per-
formance comparable to that of the normals. Cavanaugh feels 
that the results of his experiment support the view that the 
performance deficit of schizophrenics is due to impaired 
motivation. 
It is evident from the preceding review that there is 
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agreement among psychologists that the performance of chronic 
schizophrenics is impaired, relative to normals, on a variety 
of tasks including attention and reaction time. There is dis-
agreement, however, about the effects of reinforcement on the 
performance of chronic schizophrenics. It is difficult to 
draw conclusions from the various studies because they are 
not strictly comparable. Differences which exist in subject 
characteristics such as age, sex and degree of pathology, in 
the type and intensity of stimulation used, and in the tasks 
employed, make it difficult to reach any firm conclusion. 
Results from experiments that utilize normals as controls might 
be confounded by the differential stimulating value of the 
experimental arrangements for the two populations. Intuitively, 
it would be expected that such might be the case when verbal 
encouragement and 11urging-to-do-better11 are the reinforcing 
conditions. But there is also an experimental demonstration 
for such a contention in a study cited by Sands and Rodnick 
(1950) which has shown that following the presentation of a 
visual stimulus, "READY", there was a considerable difference 
in the GSR readings between normals and schizophrenics--the 
former showing the larger values--but that this difference 
disappeared when the GSR was recorded during a sound stimulus 
which followed the 11 READY" signal. 
Despite the controversial findings, however, there seems 
to be strong evidence that under positive reinforcement the 
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performance of both chronic schizophrenics and normals improves, 
but that the improvement is greater for the patients. There 
is also evidence that the performance of chronic schizophrenics 
deteriorates when presented with negative reinforcement which 
they can neither avoid nor escape. 
In a general way, these findings are explicable in terms 
of the activation theory. The performance of chronic schizo-
phrenics is impaired, relative to normals, because they are 
in a state of lower activation. Positive reinforcement raises 
the level of activation in both populations, but the performance 
improvement of the normals is smaller because they are near 
their optimum arousal to start with. Since negative reinforce-
ment has a higher arousal potential than does positive rein-
forcement, it impairs performance when it is sufficiently 
strong because it is overarousing. 
These are post hoc explanations, but they can be experi-
mentally investigated. The present study evaluates the effect 
of positive reinforcement on the performance of chronic schizo-
phrenics in the absence and presence of drugs which are 
known to depress the level of arousal. It is reasonable to 
expect that if chronic schizophrenics are characterized by a 
low level of arousal, their performance should improve under 
reinforcement, regardless of the presence or absence of other 
conditions which depress arousal. 
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C. Barbiturates 
This section will review the literature in support of 
the contention that barbiturates depress the level of activation. 
The evidence rests on the observation that barbiturates depress 
brain structures hypothesized to be instrumental in the main-
tenance of arousal, and also on the reported impairment in 
behavior which follows the administration of barbiturates. 
1. Site of Action 
Brazier (1954), Rinaldi and Himwich (1955), and Himwich 
(1960) emphasize that the cortex is an important site for 
the action of barbiturates. According to Brazier, barbiturates 
act upon cortical neurons, and this action is reflected in an 
increase of EEG activity in the cortex. Rinaldi and Himwich 
provide evidence that the electrical responses of the cortex 
of rabbits to environmental stimuli have abnormal characteristics 
after the administration of barbiturates. Himwich writes: 
• . • barbiturates depress functions of the cortical 
regions concerned with the analyzing mechanisms of 
vision, audition, and other perceptive functions--
the fine co-ordination of motor movements as well as 
thought and memory (1960, p. 58-59). 
The effects of barbiturates upon the reticular system were 
reported in a study by French, et al (1953). They found that 
ether and pentobarbital sodium depressed the reticular system 
of monkeys regardless of whether the stimulation was central 
or peripheral in origin. According to Magoun (1955), EEG 
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desynchronization which follows reticular system stimulation 
is inhibited by barbiturates. 
Bradley (1958) and Bradley and Key (1958) confirmed and 
extended the findings of French and co-workers. Cats with 
implanted electrodes were stimulated centrally within the 
reticular system and peripherally by hand clapping, blowing 
on the face, etc. EEG and behavioral arousal which followed 
such stimulation were completely blocked by pentobarbitone at 
doses higher than 3.5 mg/kg, the effect being more pronounced 
after peripheral stimulation. Lower doses had no effect. 
Since, with the proper dose, inhibition of arousal followed 
afferent and central stimulation, the authors conclude that 
the effect of barbiturates is within the reticular system 
and not on the collaterals from ascending sensory pathways as 
is the case with chlorpromazine. 
Killam and Killam (1957; 1960) in experiments with cats 
obtained results similar to those of Bradley. They report 
that consequent to the administration of pentobarbital, in 
doses well below anesthetic levels, stimulation within the 
reticular system failed to produce the normal effects upon 
the auditory system. They conclude that barbiturates exert 
a direct depressing effect upon the reticular system. 
2. Effect on Sustained Attention 
The effect of single doses of barbiturates upon the 
performance of normal subjects on a task of sustained attention 
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was investigated by Mirsky, et al (1959), Mirsky and Rosvold 
(1960), and Townsend and Mirsky (1960). According to Mirsky 
and his associates, secobarbital, pentobarbital and pheno-
barbital, each at several doses, brought about an impairment 
in performance. 
There are few published experimental studies about the 
influence of barbiturates on sustained attention in schizo-
phrenics. Wynne and Kornetsky (1960) failed to confirm a 
previous report by Huston and Singer (1945) that a barbiturate 
improved the "maintenance of set" in a reaction-time study. 
The analogy between "maintenance of set'' and 11 sustained 
attention" was discussed earlier. 
3. Effect on Psychomotor Performance 
That barbiturates impair the psychomotor performance of 
normal subjects is reported by Lehman and Csank (1957), Kornetsky 
and Humphries (1958), Kornetsky (1960), and Loomis and West 
(1960). Results similar to the ones obtained with normals 
are reported for chronic schizophrenics by Kornetsky, et al 
(1959) on several psychomotor tasks. The reaction time per-
formance of chronic schizophrenics was not, however, appreciably 
affected by either 100 or 200 mg of secobarbital (Wynne and 
Kornetsky, 1960). 
Shatin, et al (1956) found that sodium amobarbital adversely 
affected the performance of schizophrenics on several psycho-
motor tasks. Similar results were obtained by Lehman and 
Hanrahan (1954) with secobarbital on a variety of psychomotor 
tasks including reaction time. 
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The above quoted studies have all employed single dose 
administration. The effects of chronic administration are 
reported to be in the same direction. Thus, according to 
Lehman and Hanrahan (1954), Klugman (1962), and Pearl (1962) 
the chronic administration of secobarbital, amobarbital and 
phenobarbital have a depressant effect upon the psychomotor 
performance of chronic schizophrenics. 
D. Chlorpromazine 
This section will review the literature in support of 
the contention that chlorpromazine depresses the level of 
activation. As is the case with barbiturates, the evidence 
rests on the observation that chlorpromazine depresses brain 
structures hypothesized to be instrumental in the maintenance 
of arousal, as well as on the reported impairment in behavior 
which follows the administration of chlorpromazine. 
1. Site of Action 
Although the results are not uniform, there is growing 
agreement that the reticular system is one of the major loci 
for the action of chlorpromazine (Hoch, 1958; Jorgsen and 
Wulff, 1958; Margolis, 1957; Martin and Eades, 1960; Wikler, 
1959). 
There is disagreement as to whether the action of 
chlorpromazine is primarily within the reticular system or 
primarily upon the afferent collaterals that feed into the 
reticular system from the classical sensory pathways. 
When an animal is stimulated within the reticular system 
or peripherally, its EEG is activated. Chlorpromazine, when 
administered prior to central or peripheral stimulation, will 
inhibit such activation. It is inferred, therefore, that 
chlorpromazine acts within the reticular system (Unna, 1957). 
Working with implanted electrodes in rabbits, Himwich and 
Rinaldi (1957) obtained results similar to those of Unna. 
On the basis of his own work and that of others, Himwich 
(1960) feels that there is strong evidence in support of 
the hypothesis that chlorpromazine depresses the reticular 
system centrally. 
This position is challenged by other investigators, 
notably by Killam and Killam (1957) and E.K. Killam (1959). 
These authors report that in cats, doses of from 1 to 8 mg/kg 
had practically no depressant effect upon the reticular sys-
tem. These are opposite to Himwich 1 s results and, according 
to the authors, might be due to species differences. 
From a series of experiments on the central effects of 
chlorpromazine in the cat, Killam and Killam (1958; 1960) 
and Killam, et al (1957) conclude that the effect of chlor-
promazine on the reticular formation is small, but that its 
effect upon the diffuse thalamic projection system is con-
siderably more marked. Within the diffuse thalamic projection 
system there is a dissociation in the effect of chlorpromazine 
upon behavioral and EEG arousal, i.e., for a given dose the 
effects are more marked on behavioral arousal. 
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The experimental procedure of these studies was as follows: 
electrodes were implanted in the reticular formation and in the 
diffuse thalamic projection system of cats. Consequent to im-
plantation, voltage thresholds for behavioral and EEG arousal 
were determined. Following chlorpromazine administration, the 
voltage needed to bring about EEG and/or behavioral arousal 
was noted. The effect on the reticular formation was slight. 
The threshold for EEG arousal from the diffuse thalamic projec-
tion system was raised by about 4 to 5 volts, but a 7 to 13 
volt increase was necessary to bring about behavioral arousal. 
It is interesting that while the above authors do not find the 
effects of chlorpromazine upon the activating functions of the 
reticular system to be very impressive, they report a much 
stronger interaction between chlorpromazine and the inhibitory 
effects of the reticular system upon responses in the auditory 
system. Chlorpromazine enhances such inhibition (Killam and 
Killam, 1958). 
Killam and Killam (1960) speculate that the depressant 
effect of chlorpromazine on behavior is due to its selective 
facilitation of the inhibitory, downstream effect that the 
reticular formation has on afferent input. 
The experimental findings by Bradley (1958) and Bradley 
and Key (1958) are in general agreement with the findings of 
Killam, Killam and co-workers. In cats small doses of the or-
der of from 0.1 to 0.3 mg/kg of chlorpromazine, often had a 
facilitatory effect, causing EEG and behavioral arousal. 
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When the dose levels were increased up to 0.8 mg/kg, EEG 
and behavioral arousal returned to their threshold levels. 
With doses of from 2.0 to 4.0 mg/kg, there was a slight rise 
in the arousal threshold of the EEG and behavior under central 
reticular system stimulation, but almost complete blocking of 
afferent auditory stimulation. Increases in dose level did 
not enhance the effect, and at no dose level was the rise in 
threshold from central stimulation larger than 50%. The 
authors conclude that chlorpromazine acts on the afferent 
collaterals rather than within the reticular system itself. 
In a recent review of the literature, Brodie, et al 
(1961) state that the experimental findings suggest that 
chlorpromazine acts neither on the classical sensory pathways 
nor on the reticular system but rather on the afferent col-
laterals between the two. According to these authors, chlor-
promazine depresses the activity of the afferent collaterals 
by its depleting action on norepinephrine, which normally 
controls the activating effect of the afferent collaterals 
on the reticular system. 
2. Effect on Sustained Attention 
Primae, et all (1957), Mirsky, et al (1959) and Mirsky 
and Rosvold (1960) report that single 100 and 200 mg doses 
of chlorpromazine cause significant impairment in the per-
formance of normal subjects on a task of sustained attention. 
A search of the literature did not reveal similar studies 
with chronic schizophrenics. The chronic administration of 
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chlorpromazine has, according to Daston (1959), a beneficial 
effect on the attention of chronic schizophrenics. Daston's 
conclusion is based on the observation that the performance of 
chronic schizophrenics on the Immediate Recall and Paired 
Associates subtests of the Wechsler Memory Scale improved 
after they have been receiving daily doses of 400 mg of 
chlorpromazine for several months. The improvement on the 
Paired Associates subtest was statistically significant. 
Daston's conclusion, however, is open to the criticism that 
11 attention11 is not the only nor the primary psychological 
function underlying performance on a Paired Associates test. 
3. Effect on Psychomotor Performance 
The evidence indicates that chlorpromazine impairs the 
performance of normal subjects on various psychomotor measures. 
According to Brodie (1958), the reaction time performance of 
normal adults was impaired by chlorpromazine at several dose 
levels. Progressively higher doses had later peak effects, 
and the duration of effect was directly related to dose 
magnitude. Brodie reports that he could not collect data 
for doses higher than 150 mg because his subjects were unable 
to maintain sufficient alertness to perform the task. 
In recent reviews of their experimental findings, Kornetsky 
(1960) and Loomis and West (1960) have summarized evidence that 
chlorpromazine in single doses impairs performance on a 
variety of psychomotor tests. There are few experimental 
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reports in the literature on the effects of chronic chlor-
promazine administration on the performance of normal subjects. 
According to Schneider (1960) the performance of normal sub-
jects on reaction time was impaired after daily doses of 
100 mg of chlorpromazine for four days. 
Although the findings are not uniform, there is strong 
evidence that single doses of chlorpromazine of sufficient 
strength impair the psychomotor performance of chronic schizo-
phrenics, but that repeated administration has a much smaller 
effect. Furthermore, it seems to be the case that under con-
ditions of single dose administration, the performance of 
normal subjects is impaired by chlorpromazine doses too small 
to produce an equal impairment in chronic schizophrenics. Thus, 
according to Wynne and Kornetsky (1960), 100 mg of chlorpromazine 
had no effect on the performance of chronic schizophrenics on 
a reaction time task very similar to the one used by Brodie; 
and according to Kornetsky and Humphries (1958) and Lehman 
and Csank (1957), the tapping speed of normal subjects was 
impaired by 100 mg of chlorpromazine, but the performance of 
chronic schizophrenics on an identical task was not impaired 
by the same drug and dose level, according to Kornetsky, et al, 
(1959). 
Kornetsky, et al (1959) report that a single 100 mg dose 
of chlorpromazine had no appreciable effect upon the psycho-
motor performance of chronic schizophrenics. The performance 
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of the same subjects, however, was significantly impaired after 
the ingestion of 200 mg doses of chlorpromazine. After two 
weeks of daily 200 mg doses of chlorpromazine, no impairment 
in the performance of the same subjects could be detected. 
Heilizer (1959) reports that the reaction time performance 
of chronic schizophrenics did not appreciably change after 
three months of daily chlorpromazine administration. Similar 
results were obtained by Wynne and Kornetsky (1960). 
According to Lehman and Hanrahan (1954), Klugman (1962), 
and Pearl (1962), the psychomotor performance of chronic 
schizophrenics slightly improved after the chronic treatment 
with chlorpromazine. 
E. The Selective Effects of Chlorpromazine on Sustained 
Attention 
The literature review in the preceding sections concerned 
itself with the sites of action of barbiturates and chlor-
promazine and with the changes in performance which follow 
the administration of these drugs. It was indicated that the 
research findings suggest that barbiturates have a depressing 
effect upon the cortex and the reticular formation, and that 
chlorpromazine depresses the activity of the diffuse thalamic 
projection system, as well as the collaterals between the 
reticular formation and the ascending sensory pathways. The 
above neural structures are implicated in the maintenance of 
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activation. Although the evidence is not uniform, it appears 
that single doses of barbiturates and chlorpromazine impair 
performance on tasks of sustained attention and reaction time 
in normals and chronic schizophrenics. In general, then, 
the neurophysiological and psychopharmacological literature 
are in agreement. 
More recently, Kornetsky and associates (Kornetsky, 1960) 
and Mirsky and associates (Mirsky and Rosvold, 1960) have 
reported that although both chlorpromazine and barbiturates 
impair the sustained attention of normal subjects, the effect 
of chlorpromazine is more pronounced. The experimental evidence 
for this contention is more fully summarized in an as yet 
unpublished paper by Mirsky and Kornetsky. Essentially, these 
authors and their associates have compared the effects of 
chlorpromazine and barbiturates on a task of sustained attention, 
the Continuous Performance Test (CPI') and on a subtest of the 
Wechsler Intelligence Scale for Adults, the Digit Symbol Sub-
stitution Test (DSST). They report that both drugs impair 
performance on both tasks, but chlorpromazine has a greater 
effect on the CPT while barbiturates have a greater effect on 
the DSST. 
Whether the more pronounced effect of chlorpromazine on 
sustained attention, as compared to a barbiturate, is also 
evident in chronic schizophrenics will be investigated in the 
present study. 
CHAPTER III METHOD AND PROCEDURE 
A. Statement of Hypotheses 
The present study was designed to test the general hypo-
theses that: 
1. Reinforcement improves sustained attention, augments 
psychomotor output, and decreases response latency in chronic 
schizophrenics. 
2. Chlorpromazine and secobarbital impair sustained 
attention, decrease psychomotor output, and increase response 
latency in chronic schizophrenics. 
3. Relative to secobarbital, the effect of chlorpro-
mazine in chronic schizophrenics is more pronounced on sustained 
attention; less pronounced on psychomotor output and response 
latency. 
4. In the presence of reinforcement the effects of these 
drugs in chronic schizophrenics are reduced. 
The experimental arrangements were designed to provide a 
controlled comparison of the performance of chronic schizo-
phrenics on measures of sustained attention, response latency, 
and psychomotor output under conditions which would show the 
effects of reinforcement and the effects of two drugs at two 
dosage levels. Eight patients, on a balanced schedule were 
rotated through all conditions, so that each Patient served 
as his own control. In the course of twelve testing days, 
each patient had two testing days each on chlorpromazine 
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100 mg, chlorpromazine 200 mg, secobarbital 100, secobarbital 
200 mg, an inert placebo, and no medication. The testing in-
volved repeated administration of the Continuous Performance 
Test and the Subject-Paced Test, given under conditions of 
reinforcement and no-reinforcement. 
B. Independent Variables 
The effects of three independent variables were studied: 
positive reinforcement and two drugs, at two dose levels each. 
The time interval between medication and testing sessions was 
also subject to analysis. 
Since O.R. Lindsley (1957) found that candy was a better 
reinforcer than a number of other agents in schizophrenics, 
chocolate bars were used as rewards. To avoid too much of the 
same reinforcer, and since many patients smoke but are short 
34 
of cigarettes, it was decided to use both chocolate bars and 
cigarettes. The drugs used were chlorpromazine and secobarbital, 
which were administered orally in identical gelatin capsules at 
doses of 100 and 200 mg. The choice of chlorpromazine was dic-
tated by one of the aims of the study, i.e., the specific eval-
uation of the effect of this drug in relation to barbiturates 
on the behaviors under investigation. Secobarbital was chosen 
as the barbiturate because data on its effects in a normal 
population is available. This same consideration, namely com-
parison data from a normal population, also dictated the choice 
of dosage. Furthermore, the literature indicates that these 
two doses are in the range of clinical use and experimental 
usefulness, i.e., not too low to produce no observable effects, 
and not high enough to be toxic or anesthetic. 
C. Dependent Variables 
Three behavioral parameters were investigated in this 
study: the maintenance of sustained attention, response latency, 
and psychomotor output. 
"Attention" has been variously defined conceptually, but 
for the purpose of this study, Denber and Earl's definition of 
"attention" as " ••• any behavior, motor or perceptual, which 
has as its end state contact between the organism and selected 
portions of its environment" (1957, p. 91) seems most adequate. 
"Sustained attention" merely refers to the temporal dimension, 
i.e., when 11 ••• contact between the organism and selected 
portions of its environment" is demanded not once, but over 
a given period of time. Operationally, sustained attention 
was evaluated by means of the Continuous Performance Test (CPT), 
which was designed by Rosvold, et al (1956) and used as a test 
of sustained attention by these and other investigators. The 
basic performance requirment on the CPT is that the subjects 
respond by pressing a button or pulling a lever to only one 
of a series of letter stimuli, which are randomly and repeatedly 
exposed, oreat a time. In this study the letter X served as the 
critical stimulus, and it appeared on the average every fifth 
letter. Subjects were required to respod to the letter X by 
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pulling a lever. All stimuli were presented at intervals of 
1.10 seconds, and were exposed for 0.10 second. A more detailed 
description of the test apparatus is given in Appendix A. A 
subject's capacity for the maintenance of sustained attention 
was evaluated by the frequency of his omission errors (failure 
to respond to the critical stimulus), and by the frequency of 
his commission errors (responses to stimuli other than the crit-
ical stimulus), and by the frequency of his commission errors 
(responses to stimuli other than the critical one). 
"Response latency" refers to the time interval between the 
presentation of a stimulus and the completion of the required 
response. In this study the evaluation of response latency 
was also derived from the CPT. The time interval between the 
onset of the critical stimulus and the response, constituted 
the response latency. The mean response latency for a given 
trial, i.e., the cumulated response latenc~es of all the res-
ponses during a trial divided by the number of such responses, 
served as the raw score for the statistical analyses. 
Psychomotor output is conceptually ill defined, since it 
generally refers to relatively gross performance which might 
include several more refined psychomotor movements. In this 
study psychomotor output was evaluated by means of the Subject-
Paced Test (SPT), a test designed to include many of the CPT 
components, but one less dependent on sustained attention. 
The basic difference between the two tests is that on 
the SPT stimulus presentation is under the subject's control. 
The apparatus was so programmed that pulling the left of two 
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levers exposed a letter in the stimulus window which remained 
exposed until the same lever was pulled again. When the letter 
X appeared in the stimulus window, it remained exposed until 
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the right of the two levers was pulled. Two scores were de-
rived from this test: the number of lever pulls, and the num-
ber of errors, i.e., pulling the left lever when an X was exposed 
or pulling the right lever for letters other than X. The total 
number of pulls, including the right and left levers,served as 
the operational measure of psychomotor output. 
D. Subjects, Training Procedure, and Experimental Controls 
Eight male, chronic schizophrenic subjects, in the age 
range of 25 to 50 were used in this experiment. Each subject 
had been hospitalized continuously for no less than three years. 
None of the subjects was mentally deficient nor did they have 
any known organic impairment. Each subject had a medical exam-
ination to assure that his blood pressure was within normal 
range, that he was not obese, or otherwise unfit to serve as 
a subject on medical grounds. 
The training period lasted about two months. During this 
period subjects were tested without drugs but with and without 
reinforcement. During the training period, an attempt was made 
to establish the time interval during which approximately 50% 
of any given subject's responses to the critical stimulus oc-
curred under reinforcement. The apparatus was then calibrated 
for each subject individually. This procedure assured a more 
nearly equal number of reinforcements to all subjects. 
In order to minimize the possible effects of extra-
experimental variables, certain controls were instituted. 
Subjects were housed in the hospital's research ward, which 
assured a more uniform environment. The training period gave 
the subjects a chance to familiarize themselves with the labor-
atory environment and apparatus. This served to minimize the 
possible effects of stress, anxiety or exploratory behavior 
associated with the above factors. For all subjects all medi-
cation, other than experimental drugs, was discontinued for 
the duration of the training period and experimentation. 
On a testing day the ward nurse gave the medication to 
the subjects to be tested and was present while they ingested 
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the capsules. The nurse made sure that the subjects scheduled 
for testing did not eat breakfast, and that they were accompanied 
to the laboratory if they had no parole. Neither the ward nurse 
nor the other personnel were aware of the nature of the drugs, 
nor did they know whether a subject was receiving a placebo 
or an active agent. For the duration of testing subjects were 
not allowed to smoke or eat. 
E. Schedule 
The drugs were administered according to a modified Latin 
Square design. Each subject served as his own control and was 
given medication once weekly for 12 weeks. Table 1 illustrates 
TABLE 1 
EXPERIMENTAL DRUG SCHEDULE 
Weeks 
Subject I II III IV v VI 
A 
B 
c 
D 
E 
F 
G 
H 
1 2 
2 1 
3 4 
4 3 
4 3 
3 2 
1 4 
2 1 
No entry = no drug 
0 =placebo 
0 3 
0 4 
0 1 
0 2 
0 1 
0 4 
0 2 
0 3 
1 = chlorpromazine 100 mg 
2 = chlorpromazine 200 mg 
3 = secobarbital 100 mg 
4 = secobarbital 200 mg 
4 
3 
2 
1 
2 
1 
3 
4 
VII VIII IX X 
3 1 0 4 
4 2 0 3 
2 4 0 1 
1 3 0 2 
2 3 0 1 
4 1 0 3 
1 2 0 4 
3 4 0 2 
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XI XII 
2 
1 
3 
4 
4 
2 
3 
1 
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the drug schedule. The table shows that all the active drugs 
were administered to each subject twice, and that the order is 
completely balanced, i.e., each active drug condition followed 
any other drug condition an equal number of times. Placebos 
were given to each subject in the fourth and ninth testing days. 
As is seen from Table 1, no subject received medication on the 
first and last days of the experiment. The no-medication con-
dition was introduced for two reasons: it provided a baseline 
of performance against which the performance under placebo could 
be evaluated, and it allowed for the determination of practice 
effects. 
The order in which the tests and the reinforcement were 
administered was also balanced. Half of the subjects were 
tested on the CPT first and the SPT second during testing days 
1 to 6 and were tested on the SPT first and CPT second during 
testing days 7 to 12. For the other half of the subjects the 
order of test administration was reversed. 
During each testing session, one trial each on the CPT 
and SPT was reinforced, and one trial each on the CPT and SPT 
was not reinforced. For half of the subjects the first trial 
on the CPT and SPT was reinforced during testing days 1 to 6 , 
while during testing days 7 to 12 the second trial on each 
test was reinforced. For the other half of the subjects, 
the order was reversed. 
A testing day consisted of four sessions, every hour on 
the half hour after drug administration, i.e., testing began 
one-half hour after a subject received medication, and the 
last session began three and a half hours after drug adminis-
tration. A session lasted approximately half an hour and con-
sisted of two CPT trials and two SPT trials, one of each being 
reinforced. A visual stimulus indicated to the subject whether 
or not the trial would be reinforced. Fifty critical stimuli 
were presented during a CPT trial, this number remaining in-
variant for all occasions. An SPT trial lasted three minutes. 
F. Operational Hypotheses 
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The independent and dependent variables, and the operational 
procedures to measure the relationships between the two having 
been defined, the following operational hypotheses were formulated: 
On the CPT: 
1. Under reinforcement the number of omission errors and the 
number of commission errors is smaller than under no reinforce-
ment. 
2. Under reinforcement the response latency is shorter than 
under no reinforcement. 
3. Under the active drug conditions the number of omission 
and commission errors is greater than under placebo; the larger 
doses have the greater effect; and the effec~ of chlorpromazine 
and secobarbital are alike. 
On the SPT: 
1. Under reinforcement the number of responses is greater 
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than under no reinforcement. 
2. Under the active drug conditions the number of res-
ponses is smaller than under placebo; the larger doses have 
the greater effect; and the effects of chlorpromazine and 
secobarbital are alike. 
G. Statistical Treatment 
Two analyses of variance for correlated scores were per-
formed on each dependent variable. 
The first analysis evaluated the possible effect of 
placebo, as compared to the no-drug condition, as well as 
the variance associated with repeating the no-drug and placebo 
conditions twice. In this analysis the reinforced and non-
reinforced trials were evaluated separately. Table 1, Appendix 
B, shows the model for this analysis. It should be noted that 
the error term is based on all the pooled interactions 
involving "subjects". However, in order not to inflate the 
significance values, the number of degrees of freedom used 
to enter the F Table were based on the number associated with 
"subjects". 
If the statistical comparison between the placebo and 
no-drug conditions was found to be non-significant, the latter 
was excluded from further statistical analysis. When the 
difference between the two testing periods proved to be 
statistically nonsignificant, the scores from the two testing 
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periods for all drug conditions were pooled and the mean of 
the pooled scores for each subject served as the raw score for 
further analysis. 
The second analysis served to evaluate the reinforcement 
and drug effects, as well as the interactions between them. 
Table 2, Appendix B, shows the model for this analysis. As 
in the previous model, the sums of squares of all the inter-
actions involving the subjects term were pooled to form the 
error term. Consequently, the mean square for error is based 
on 273 degrees of freedom. Entries into the F table, however, 
were made with the number of degrees of freedom associated with 
the particular source of variance and its interaction with 
the subject term, thus avoiding inflated significance values. 
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CHAPTER IV. RESULTS 
The statistical tests of the differences in performance 
under the placebo and no-drug conditions revealed no signifi-
cant differences between the two conditions on any dependent 
variable of the experiment. The scores from the no-drug 
condition were, therefore, excluded from further statistical 
treatment. 
In the case of all the dependent variables, except number 
of responses on the SPT, there was no significant difference 
in performance between the two periods. In the further 
analyses, therefore, the SPT scores from each period were 
analyzed separately, while the scores from both periods of the 
other dependent variables were pooled. 
The results from the analyses of variance of each dependent 
variable are reported in Appendix C. 
A. The Effect of Reinforcement 
The findings confirm the hypothesis that in chronic schizo-
phrenics reinforcement improves sustained attention, decreases 
response latency, and augments psychomotor output. 
Table 2 presents the mean values for the reinforced and 
non-reinforced trials and the F and P values for reinforcement 
as a source of variance from the analyses of variance. Each 
mean was arrived at by summing over all drug conditions and 
over the four test sessions per day, for the reinforced and 
non-reinforced trials separately, and dividing each sum by 160. 
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TABLE 2 
Effect of Reinforcement on Mean Performance Scores 
Reinforced Non-Reinforced F 
Trials Trials (1&7df) p 
Mean Number Omission Errors 6.14 9. 09 14.31 <. 01 
Mean Number Commission Errors 2.61 1. 90 14.96 <. 01 
Mean Response Latency in Sec. . 58 • 63 43.62 <. 0005 
Mean Number of Response (SPT) 
1st Period 21.34 19.87 27.59 <. 0005 
2nd Period 22.34 20.92 25.34 <.0005 
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As Table 2 shows, in the presence of reinforcement, the 
average number of omission errors is smaller than in the 
absence of reinforcement; the average response latency is 
shorter in the presence of reinforcement; and the average 
number of responses on the SPT is larger for the reinforced 
trials. Furthermore, Table 2 shows that the differences 
between the reinforced and non-reinforced trials for each 
of the above dependent variables are statistically signifi-
cant. This supports the conclusion that under reinforcement 
the performance of chronic schizophrenics improves. 
It will be noted, however, that in the case of commission 
errors, the results are opposite to the prediction. The mean 
number of commission errors is larger for the reinforced rather 
than the non-reinforced trials, and the difference between 
the two is statistically significant. This negative finding, 
however, may be reconciled with the confirmation of the hypo-
thesis if it is assumed that during reinforcement the subjects 
were more highly motivated, and therefore pulled the lever at 
times when only a partial cue of the critical stimulus was 
perceived. 
B. The Effect of the Drugs 
The findings in general confirm the hypothesis that in 
chronic schizophrenics, chlorpromazine and secobarbital impair 
sustained attention, increase response latency, and decrease 
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psychomotor output--the higher doses having the greater effect. 
These findings are most clear with respect to the chlor-
promazine effects. As will be discussed more fully later, 
secobarbital had a much shorter duration of action; con-
sequently, the effects of this drug are more evident when it 
is compared to placebo during its peak effect rather than 
over the four post-drug testing sessions. 
Table 3 presents the mean values of the dependent variables 
for each drug condition and the significance values associated 
with the "drug" term in the analyses of variance. Each mean 
was arrived at by summing over the two reinforcement conditions 
and over the four test sessions per day and dividing the sum 
by 64, which is the total number of cell entries for each 
drug condition. An inspection of Table 3 shows that in the 
case of each dependent variable, performance was best during 
the placebo condition; or conversely, the table shows that 
all drug conditions impaired performance on all the measures 
that were taken. Thus, the number of omission and commission 
errors is greater under each of the active drug conditions 
than it is under placebo, the response latency is longer under 
the active drug conditions than under placebo, and the number 
of responses on the SPT during both periods is smaller for 
the active drug conditions than for placebo. 
That the differences in performance under placebo and 
the other drugs are not due to chance is revealed by the 
TABLE 3 
Effect of Drug Conditions on Mean Performance Scores 
CPZ CPZ Seco Seco F 
Placebo 100 mg 200 mg 100 mg 200 mg (4 & 28 df) 
Mean Number Omission Errors 4.8 8.9 12. 0 5. 3 7.2 11. 26 
Mean Number Commission Errors 1.8 2. 0 2.8 2. 0 z. 7 4.65 
Mean Response Latency in Seconds • 56 . 60 .65 . 59 . 64 20.00 
Mean Number of Responses (SPT) 
1st Period 21.84 20.82 19.63 21.33 19.39 11. 75 
2nd Period 22.79 21. 66 20.67 22. 12 20.92 7.59 
p 
< . 0005 
< . 01 
< .0005 
< . 0005 
<. 001 
.j::--
00 
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significant F values associated with the 11 Drug'' term of each 
dependent variable. In order to determine whether performance 
under each individual drug condition was significantly differ-
ent than performance under placebo, significance tests were 
performed with Dunnett's Test for comparisons with a control 
(Edwards, 1960). Table 4 presents the results of these com-
parisons. Since the hypotheses predicted that the drugs will 
impair performance, all comparisons are based on a one-tailed 
test. As this table indicates, some of the comparisons did 
not reach statistical significance. The 100 mg dose of seco-
barbital did not significantly differ from placebo in its 
effect on sustained attention and psychomotor output, but did 
significantly affect response latency. The 100 mg dose of 
chlorpromazine did not significantly differ from placebo on 
commission errors, but differed significantly on all other 
measures. The 200 mg dose of secobarbital significantly 
impaired psychomotor output and response latency, but differed 
significantly from placebo on only one of the two measures of 
sustained attention, i.e., commission errors. The difference, 
however, approached the .05 level of significance on the omission 
errors: the numerical difference between this condition and 
placebo was 2.40 and the value required for significance is 
2.78. The 200 mg dose of chlorpromazine was significantly 
different from placebo on all dependent variables. 
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TABLE 4 
Dunnett's Test of Differences Between Placebo 
and Active Drug Conditions 
Source 
Placebo-
CPZ 100 mg 
Placebo-
CPZ 200 mg 
Placebo-
Seco 100 mg 
Placebo-
Seco 200 mg 
SPT 
Omission Commission Response Number Responses 
Errors Errors Latency 1st Period 2nd Period 
<. 01 <. 01 <.05 <. 05 
<. 01 <.01 <.01 <. 01 <. 01 
<· 01 
51 
The data summarized in Tables 3 and 4, then, support the 
hypothesis that both chlorpromazine and secobarbital impair 
the performance of chronic schizophrenics on the measures 
under study. Table 3 also shows that for each dependent 
variable, the larger dose of each drug had a greater effect 
than the smaller dose. For example, while the mean number 
of omission errors under 100 mg of chlorpromazine is 8.9, the 
comparable value for 200 mg of chlorpromazine is 12.0. The 
significance of the differences between the effects of both 
doses of both drugs was evaluated by means of the method of 
orthogonal comparisons (Edwards, 1960). Since four degrees 
of freedom are associated with the 11 Drug" term, four orthogonal 
comparisons are permissible. Table 5 presents the results 
of these comparisons. As is seen from the table, in all cases 
but one (omission errors) the differences between the 100 and 
200 mg doses for both drugs.are statistically significant. 
Reference to Table 3 shows that in all cases the greater impair-
ment in performance occurred under the higher doses. 
C. The Dissimilar Effects of the Drugs 
The findings in general support the hypothesis that 
relative to secobarbital, the effect of chlorpromazine in 
chronic schizophrenics is more pronounced on sustained attention, 
but not on psychomotor output and response latency. 
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TABLE 5 
Orthogonal Tests of Differences Among Drug Conditions 
SPT 
Omission Commission Response Number Responses 
Source Errors Errors Latency 1st Period 2nd Period 
Placebo-
All Drugs <.0005 <.025 <.0005 <.0005 <.0005 
Chlorpromazine-
Seco. <.0005 
CPZ 100 mg-
CPZ 200 mg <.05 <. 01 <. 0005 <.025 <. 05 
Seco 100 mg-
Seco 200 mg <. 05 < • 0005 <. 0005 <. 025 
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In comparing the effects of chlorpromazine and secobarbital, 
however, the different time-response curves of the two drugs 
must be considered. Figures 1, 2, 3, 4, and 5 illustrate the 
time-response curves of the two drugs with respect to the 
dependent variables of this study. The statistical signifi-
cance of these relationships is evident from the tables in 
Appendix C which show that the Drugs X Hours interaction is 
significant for each dependent variable, except errors of 
conunission. 
Figure 1 shows that with respect to omission errors, seco-
barbital has its maximum effect 1/2 hour after administration, 
that chlorpromazine is approaching its peak effect 3 1/2 hours 
after administration, and that the effect of placebo does not 
appreciably change from hour to hour. This figure also shows 
that both doses of each drug have a similar time course 
although they differ in magnitude of effect at each hour. 
Figure 2 shows a basically similar relationship between 
the drugs with respect to conunission errors, except that the 
100 mg dose of either drug does not vary much from placebo. 
As is seen from this figure, 200 mg of secobarbital has its 
maximum effect 1/2 hours after administration and declines 
thereafter; while 200 mg of chlorpromazine has very little 
effect 1/2 hour after administration, but its effect increases 
steadily thereafter. 
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Figure 3 shows the time-response curve of the drugs with 
respect to the response latency measure. Again, the peak 
effect of secobarbital is evident 1/2 hour after administration; 
while the effect of chlorpromazine is negligible 1/2 hour 
after administration, but increases steadily thereafter. 
During the last post-drug testing session, the chlorpromazine 
effect is approaching its peak. Figure 3 also shows that 
both doses of each drug have similar time courses, and that 
performance under placebo changes little from hour to hour. 
As is seen from Figures 4 and 5, the peak effect of seco-
barbital with respect to the number of responses on the SPT, 
as in the case of all other measures, is 1/2 hour after drug 
administration; chlorpromazine, however, reaches its peak 
2 1/2 hours after drug administration, which is earlier than 
in the case of the other measures. It will be noted in 
Figure 4 that the placebo curve shows an acceleration from 
the first to the fourth testing session. This increase is 
significant, as indicated by the significant P value for 
Hours on this measure in Table 4, Appendix c, and it is the 
only case where placebo performance was significantly different 
between any two testing sessions during the same day. 
Since the time-response curves of the two drugs are 
different, the evaluation of their relative effects on the 
behaviors under study is based on the comparison between their 
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peak effects. Figures 6 and 7 show the results of these 
comparisons. In Figure 6, the effects of the 100 mg doses of 
both drugs on the dependent variables are compared, while 
Figure 7 presents the comparisons between the 200 mg doses 
of both drugs. 
Figure 6 shows that at its peak, the effect of 100 mg of 
chlorpromazine was more pronounced on omission errors and 
response latency, and that both drugs had an identical effect 
on the other dependent variables. As is seen from Figure 6, 
none of the comparisons are statistically significant. 
The selective effects of chlorpromazine on sustained 
attention are more pronounced with the higher doses (Figure 7). 
Although none of the differences in Figure 7 are statistically 
significant, they clearly demonstrate the dissimilar effects 
of the drugs. Thus, the effect of the 200 mg chlorpromazine 
dose is greater on omission and commission errors, and the 
reverse is true for number of responses on the SPI' and response 
latency. 
D. The Effect of the Drugs in the Presence of Reinforcement 
The findings confirm the hypothesis that in chronic schizo-
phrenics the effects of chlorpromazine and secobarbital are 
reduced in the presence of reinforcement. 
As was noted earlier (See Table 2), reinforcement signifi-
cantly improves performance on all dependent variables except 
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errors of commission. That the reinforcement effect is similar 
over all the experimental drug conditions is evident from the 
absence of a significant Drug X Reinforcement interaction (See 
Table 8). Figures 8, 9, 10, and 11 give a graphic illustration 
of the changes in the mean performance scores of the dependent 
variables under the experimental conditions. Table 8 
summarizes the statistical results from the analyses of 
variance and the multiple comparison tests. In all figures 
the experimental conditions are plotted along the horizontal 
baseline, and the means along the vertical. As is evident 
from these figures, the overall effect of the active drugs 
is to impair performance; and the overall effect of reinforce-
ment is to improve performance. Furthermore, the reinforcement 
effect is independent of the particular experimental conditions, 
having a nearly identical effect in the presence of all the 
active agents. 
Table 8 indicates the significance values associated with 
the different sources of variance, as well as the significance 
values associated with the interaction terms for each dependent 
variable. The effect of "Drugs 11 and 11Reinforcement" on per-
formance is significant on all measures taken. The interaction 
between these two terms is not significant. The absence of a 
significant interaction between drugs and reinforcement 
indicates that both effects are independent of each other, i.e., 
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the drugs impair performance on all measures in the presence 
of reinforcement and in the absence of reinforcement, while 
reinforcement improves performance in the presence and absence 
of the active drugs. 
In the case of all measures but one, repeated testing 
during the same half day has no significant effect on performance. 
This is evident from the non-significant "Hour" effect. The 
one exception is the first period of the number of responses 
(SPT). In this case performance during the fourth post-drug 
session, independent of all other conditions, was significantly 
better than during the first post-drug session. 
While the effect of 11 Hours" is not significant, the inter-
action between "Hours" and "Drugs" is significant in all cases 
but one. This indicates that except in the case of commission 
errors, the time-response curves of the different drug conditions 
are significantly different from each other. As was discussed 
earlier (See Figures 1 to 5), within the time limits of this 
experiment, the effect of secobarbital was greatest 1/2 hour 
after administration and declined fairly rapidly thereafter; 
while chlorpromazine had no detectable effect 1/2 hour after 
administration, but its effect increased steadily thereafter 
to a peak at 3 1/2 hours after administration. 
The effect of reinforcement is not significantly differ-
ent during any of four testing sessions of the same day. This 
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is evident from the absence of a significant interaction between 
l!Reinforcement" and "Hours". 
The triple interaction between "Drugs", "Reinforcement", 
and "Hours" is not significant. 
Table 8 also summarizes the results of the Orthogonal 
Comparisons and Dunnett's Test. The table shows the signifi-
cance value of the differences in the various comparisons. 
Absence of an entry indicates that the two conditions did not 
differ significantly in their effect on the particular measure. 
Thus, as the table shows, performance on all measures under 
200 mg of chlorpromazine is significantly different from per-
formance under placebo, while performance under 100 mg of 
secobarbital is significantly different from performance 
under placebo only in the case of response latency. 
TABLE 6 
Tabular Summary: Results of the Analyses of Variance, 
The Orthogonal Comparisons and the Dunnett's Test 
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SPT 
Omission Commission Response Number Responses 
Source Errors Errors Latency 1st Period 2nd Period 
Drugs <. 0005 
~~CPZ 100 mg -
CPZ 200 mg <. 05 
*Seco 100 mg -
Seco 200 mg 
~:~Placebo -
All Drugs <· 0005 
-"**Placebo -
CPZ 100 mg <· 01 
~~*Placebo -
CPZ 200 mg <. 01 
*~!<Placebo -
Seco 100 mg 
~~~~Placebo -
Seco 200 mg 
Reinforcement <· 01 
Hours 
Drugs X Rein£. 
Drugs X Hours<. 0005 
Rein£. X Hours 
Drugs X Rein£. 
X Hours 
~~Orthogonal Comparisons 
~:~~:~Dunnett's Test 
< • 01 <. 0005 <. 0005 <. 001 
<.01 <.0005 <.025 <. 05 
<.05 <.0005 <.0005 <. 025 
<. 025 <. 0005 < • 0005 < .001 
<.01 <.05 < .05 
<. 01 <. 01 <. 01 < .01 
<.05 
<. 01 <. 01 <. 01 <. 01 
<. 01 <. 0005 <. 0005 <. 0005 
<.01 
< • 0005 <.0005 < • 0005 
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CHAPTER V. DISCUSSION 
This chapter will relate the findings from the present 
study to those reported by other investigators. For ease of 
exposition, the findings relating to each of the general hypo-
theses (p. 33) will be discussed in a separate section. A 
section will be devoted to the relation of the present findings 
to the activation theory, and a final section to suggestions 
for further research. 
A. The Effect of Reinforcement 
There is almost universal agreement that attention and 
psychomotor performance are impaired in schizophrenia. With 
respect to psychomotor impairment, the conclusion is derived 
from the comparison of the performance of chronic schizophrenics 
and normals on a large number of simple and complex psycho-
motor tasks. Although there is some evidence that the degree 
of impairment may be task specific, chronic schizophrenics 
are generally impaired relative to normals on almost all psycho-
motor tasks. The conclusion with respect to attention is 
based on clinical observations and indirect measurements, since 
tests designed to measure attention specifically are rare. As 
previously stated, reaction time studies which utilize prepara-
tory intervals provide a good measure of sustained attention, 
and the concept of "preparatory set", which is invoked as 
essential in such performance, is very similar if not identical 
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to the definition of "sustained attention." Such reaction time 
studies have repeatedly demonstrated that relative to normals, 
the performance of chronic schizophrenics is impaired. 
The results are inconclusive as to whether these per-
formance deficits of chronic schizophrenics are modifiable in 
the presence of reinforcement. It is reported that positive 
verbal reinforcement, material rewards, and the cessation of 
shock or noise bring about an improvement in the performance 
of chronic schizophrenics. Improvement is also reported to 
take place when the tasks are made more interesting or when 
the experimenter urges the patients to perform better. Nega-
tive reinforcement, on the other hand, and tasks which are per-
ceived as ego threatening are reported to impair the performance 
of chronic schizophrenics. Other studies, however, report no 
improvement in the performance of chronic schizophrenics in 
the presence of positive reinforcement, while others report 
improvement on some tasks only, or by some subjects only or 
both. 
It is not possible to draw firm conclusions from the 
literature because the different studies are not strictly 
comparable. The studies vary with respect to the experimental 
arrangements, including such variables as sex, age, degree of 
pathology, and years of hospitalization of the subjects, as 
well as nature of the tasks, nature of the reinforcement 
conditions, and types of controls. The findings in general 
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suggest that the effect of positive reinforcement may be task 
specific, having a more pronounced effect on the performance 
on simple tasks. It also seems that reinforcement effects 
interact with subject characteristics. For example, positive, 
verbal reinforcement seems to improve the performance of 
more intact patients to a greater extent than it does the 
performance of more deteriorated patients, while the reverse 
seems to hold for the deleterious effects of negative reinforce-
ment. 
The effect of reinforcement upon the tasks of this study 
was not previously investigated. Since the literature indicates 
that the effects of reinforcement upon the performance of 
chronic schizophrenics may be task specific and may depend on 
the nature of the subjects, generalizations from the present 
findings may have to be somewhat limited. In the most general 
case, the findings from the present study permit the inference 
that in the presence of positive reinforcement, the sustained 
attention and psychomotor performance of chronic schizophrenics 
improves. 
There are several implications in the present findings 
with respect to the effect of reinforcement. On a theoretical 
level, the general relationships between reinforcement and 
performance established for various populations are found in 
chronic schizophrenics as well. This point will be elaborated 
74 
upon more fully in a later section where the relationship 
between the present findings and the activation theory are 
discussed. The findings also imply that the behavior of 
chronic schizophrenics can be modified by the manipulation 
of incentive conditions, or conversely, that the behavior of 
chronic schizophrenics in a given situation may not be fully 
understood unless the reinforcement characteristics of that 
situation are known. 
This last point is demonstrated in the present study. 
As was earlier shown, the effect of reinforcement was evident 
to the same degree in the presence of placebo and the active 
drugs. Studies in animals have repeatedly demonstrated the 
importance of reinforcement schedules in the modification of 
the observable effects of drugs. Similar studies with chronic 
schizophrenics are rare. But the present findings suggest that 
the toxic behavioral effects of psychoactive drugs in chronic 
schizophrenics may be reduced in the presence of reinforcement. 
B. The Effect of the Drugs 
It was emphasized in the previous section that due to 
sampling variability and differences in experimental design, 
it is difficult to draw valid conclusions from studies of chronic 
schizophrenics or explain discrepant findings. The same con-
siderations apply to drug studies. These objections are less 
pertinent with regard to drug studies of normal persons, since 
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they usually employ samples from more homogeneous populations; 
namely, volunteer, male college students or attendants in 
mental hospitals. Drug studies of normals and chronic schizo-
phrenics differ with respect to another very important variable, 
i.e., the duration of drug administration. On the whole, the 
reported experiments with normals are single dose studies; while 
those with chronic schizophrenics are chronic drug studies. 
There is ample pharmacological evidence that the single dose 
effects of many compounds are unlike those of chronic adminis-
tration. 
These considerations limit the extent to which valid 
comparisons can be made concerning the effects of drugs on 
normal persons and chronic schizophrenics. Evidence, however, 
has been accumulating that barbiturates impair the performance 
of normal persons and chronic schizophrenics whether given once 
or over time. Single doses of chlorpromazine also impair the 
performance of normal persons and chronic schizophrenics, but 
upon repeated administration, the toxic behavioral effects of 
chlorpromazine are less evident in chronic schizophrenics. 
This suggests that chronic schizophrenics develop tolerance 
to chlorpromazine but do not develop tolerance to barbiturates. 
From the limited evidence available, it appears that normal 
persons do not develop tolerance to either chlorpromazine or 
barbiturates. 
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Uhr (1960) arrived at a similar conclusion with respect 
to the effects of chlorpromazine. He writes: 
The relatively few studies of chronic drug 
effects on patients in which laboratory tests, rather 
than the more traditional diagnostic batteries, have 
been used give a picture of minimal behavioral toxic 
effects from the tranquilizers tested. There are 
indications that these are smaller for patients than 
for normal subjects . . . (p. 623). 
Some studies have reported that not only did chronic 
schizophrenics develop tolerance to the effects of chlor-
promazine after repeated administration, but that their per-
formance on psychomotor and other tasks improved. It has to 
be emphasized, however, that any reported improvement in per-
formance as a result of the repeated administration of a drug 
cannot, by itself, be interpreted as due to the drug's 
specific action on the behavior studied, since the results 
may be confounded with clinical improvement. 
The present findings show that the sustained attention 
and psychomotor performance of chronic schizophrenics is 
impaired under single doses of chlorpromazine and seco-
barbital. The findings also indicate that the impairment in 
performance is a function of the dose, the higher doses having 
a larger effect, and the time elapsed after the administration 
of the drug. The effects of secobarbital are evident only a 
short time after administration and decline relatively 
rapidly thereafter. The effects of chlorpromazine are small 
up to about one and a half hours after administration, but 
are quite evident for two hours therafter. 
When the results from the present study are compared with 
findings in normals, it appears that on similar tasks the per-
formance decrements produced by barbiturates are similar in 
normals and chronic schizophrenics, but that the performance 
decrement caused by chlorpromazine is more pronounced in nor-
mals. Such a comparison, with respect to omission errors on 
the CPT, appears in Appendix D. 
As is seen from the table in Appendix D, 200 mg of seco-
barbital produced a very similar decrement in the performance 
of normal subjects and the subjects of the present study, but 
the chlorpromazine effects, especially for the higher dose, 
were much more pronounced in the normal subjects. 
It appears, then, that chronic schizophrenics are as 
vulnerable as normals to the toxic behavioral effects of bar-
biturates, but that they are less vulnerable to the toxic 
behavioral effects of chlorpromazine. This dissociation in 
the effects of the two types of drugs in the two populations 
may be explained in neurophysiological terms or in more be-
havioral-psychological terms. It is likely that the receptor 
sites for chlorpromazine in the central nervous system are in 
some way altered in chronic schizophrenics as compared to nor-
mal persons. Ultimately, neurophysiological research may pro-
vide direct evidence on this question. But it is of interest to 
note that the midbrain receptor sites for both drugs, although 
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within the reticular system, are thought to be anatomically 
distinct (Killam and Killam, 1957; 1958; 1960; Bradley and 
Key, 1958). 
The dissociation in the effects of the drugs, may also 
be explained in terms of a difference in the psychological 
reaction of normal persons and chronic schizophrenics to the 
pharmacological activity of the drugs. In a review of the 
pharmacological literature, Pelikan and Kensler (1958) have 
concluded that the peripheral changes which are induced by 
chlorpromazine are more extensive than are the peripheral 
effects of barbiturates. They write: 
Sedative agents can also produce side effects 
referable to actions on peripheral systems. In 
therapeutic doses, such sedative agents as the 
barbiturates • . • seldom produce effects on systems 
other than the central nervous system (p. 12). 
According to these authors, the incidence of side effects, 
such as tachycardia, hypotension, hepatotoxicity and dry 
mouth are more common after the administration of chlor-
promazine. 
The behavioral deficits, then, which are produced by 
chlorpromazine and secobarbital may be conceptualized as 
having two components: a central component and a peripher-
al one. Normals and chronic schizophrenics are affected by 
both, but chronic schizophrenics react to a lesser degree 
to the peripheral changes than do normals. 
This less pronounced psychological reaction of chronic 
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schizophrenics to induced alterations in their internal environ-
ment may be understood in terms of the different life histories 
of chronic schizophrenics and normal, young adults (as are most 
subjects in psychopharmacological experiments). Even on a super-
ficial level, the differences are great: the patients have had a 
variety of physical treatments and years of regimented conformity 
to a mental hospital environment, to mention just two factors. 
The present finding that inert capsules (placebos) do not 
significantly affect the performance of chronic schizophrenics is 
in agreement with other published reports. Identical results 
were obtained in another acute study (Wynne and Kornetsky, 1960) 
as well as in studies with a six-week-placebo condition (Pishkin, 
1962), and a twelve-week-placebo condition (Pearl, 1962). It is 
of interest to note that in the above-mentioned study by Pishkin, 
the test employed was the CPT. The findings reported by him to-
gether with those of the present study indicate that the CPT is a 
reliable measure even with chronic schizophrenics who are known to 
display considerable inter- and intra-subject variability. 
As was earlier discussed, Kornetsky (1960) and Mirsky and 
Rosvold (1960) report that in normal subjects chlorpromazine 
has a selective effect on a test of sustained attention, while 
barbiturates have a selective effect on a more cognitive-type 
test. Mirsky and Kornetsky (unpublished) have summarized 
electroencephalographic, neuropharmacological, and behavioral 
evidence to show that there are different neural organizations 
which mediate performance on these two types of tests. It is 
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suggested that these neural organizations are differentially 
sensitive to the effects of chlorpromazine and barbiturates. 
Findings from the present study indicate that the selec-
tive effect of chlorpromazine on sustained attention is also 
present in chronic schizophrenics. In the present study, the 
comparison between the action of chlorpromazine and secobarbi-
tal is based on their selective effects on sustained attention, 
response latency and psychomotor output. These findings in-
dicate that when evaluating the effects of chlorpromazine on 
a given task, the possible role of sustained attention in the 
performance on the given task has to be considered. 
C. Relation to the Activation Theory 
The findings from the present study suggest that chronic 
schizophrenics are normally at a level of hypoactivation. The 
evidence for this suggestion rests on the data from this 
experiment which show that in the presence of the drugs per-
formance was impaired, while in the presence of reinforcement 
performance improved. The evidence that chlorpromazine and 
secobarbital lower the level of arousal, and that reinforce-
ment heightens the level of arousal was reviewed in an earlier 
chapter. Since the placebo-drug differences in this study 
were in most cases more pronounced than the differences be-
tween the reinforced and non-reinforced trials (whether during 
placebo or drug sessions), it would appear that the effects of 
the drugs on arousal are more pronounced than the reinforce-
ment effects. It need be emphasized, however, that such 
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quantitative comparisons cannot be generalized but have 
specific reference to the exact variables of this study, i.e. 
it is quite possible that other reinforcement conditions would 
have an effect different from that of the present study. 
A further note of caution with regard to the above con-
clusion stems from the absence of physiological measures of 
activation in the present study. Although it is reasonably 
well established by techniques independent of behavioral meas-
urement that chlorpromazine and secobarbital cause a drop in 
the level of arousal, such independent confirmation of the 
effects of reinforcement is less extensive. Despite the ab-
sence of independent physiological confirmation, conceputal-
izing the data within the activation theory is of value in that 
it can be related to a systematic body of knowledge and theory. 
This is especially true for the present finding that when pre-
sent together the drugs and reinforcement counteract each other 
others effects, as would be predicted by the activation theory. 
If reinforcement raises the activation level of chronic 
schizophrenics, why is this not reflected in improved per-
formance in some of the studies which investigated the effects 
of reinforcement? One explanation rests on the possibility 
that intended reinforcers had no such value. It can also be 
explained in terms of sample differences. Given the hetero-
geneous nature of schizophrenics, it is possible that some 
schizophrenics are normally in a state of high arousal. Con-
sequently, further increases in arousal would tend to impair 
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performance rather than improve it. In one study, for example, 
Malmo, et al (1951) found that a group of chronic schizophrenics 
had a higher degree of spontaneous central nervous system activ-
ity than a group of normal controls. This explanation would 
apply to reports that the performance of chronic schizophrenics 
improves after the acute administration of chlorpromazine. 
Patients who are normally highly aroused should perform better 
when their level of activation is decreased towards a more 
optimum middle level. Studies, however, which report no im-
provement under reinforcement, or improvement under single 
doses of chlorpromazine, are the exception rather than the 
rule. 
From a comparison of the present findings with those re-
ported from studies of normal subjects, it appears that chronic 
schizophrenics are characterized by a lower level of arousal 
than are normals. It has been repeatedly demonstrated by many 
workers that the performance of chronic schizophrenics rela-
tive to normals is impaired on a large number of tasks. By 
reference to the postulated relationship between performance 
and arousal, chronic schizophrenics could be inferred to be 
either overaroused or underaroused. Since the present find-
ings indicate that chronic schizophrenics function at a level 
of activation below that for best performance, the inference 
seems justified that they are characterized by a lower level 
of activation than are normals. 
The foregoing discussion is based on the assumption that 
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the theoretical model provided by the activation theory applies 
to chronic schizophrenics as well as to normals. Although the 
present findings support such an assumption, in the absence 
of physiological measures they are only suggestive. In normals, 
for example, Mirsky and Cardon (1962) have shown that errors of 
omission, after sleep deprivation or 200 mg of chlorpromazine, 
were associated with a slowing of the EEG, increased finger 
pulse amplitude, and an increase in the length of the respir-
atory cycle. It would be of value to study schizophrenics in 
an analogous fashion for there are some indications that under 
certain conditions the correlation between behavioral measures 
and performance may be different for chronic schizophrenics 
than for normals. A study by Fedio, et al (1961) illustrates 
this point. These authors compared the performance of normal 
and chronic schizophrenic subjects on a reaction time test 
during which EEG recordings were made. There was no differ-
ence in the speed of reaction of the two groups when EEG alpha 
activity was present, but when alpha was blocked by an auditory 
stimulus, the reaction time of the normals improved whereas 
the reaction time of the schizophrenics became even slower. In 
this case, then, there was a dissociation between a physiologi-
cal and behavioral response. The authors suggest that their 
findings support the hypothesis that EEG activation and be-
havioral arousal might be mediated by two different neural 
systems, and that the neural system which mediates behavioral 
arousal may be altered in chronic schizophrenics. 
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It is also likely, however, that the effect of a given 
auditory stimulus is not the same for normals and chronic 
schizophrenics. That the meaning of a stimulus may measure-
ably affect the level of activation, and that a given stimulus 
may have a different meaning or differential reinforcing char-
acteristics for normals and chronic schizophrenics was previously 
illustrated and discussed. It is possible, therefore, that the 
chronic schizophrenic subjects in the study by Fedio, et al 
were highly aroused by the auditory stimulus and that conse-
quently their performance was impaired. 
D. Suggestions for Further Research 
The present findings show that in the presence of posi-
tive reinforcement, the performance of chronic schizophrenics 
improves. The results also show that the impairment in per-
formance under chlorpromazine and secobarbital is reduced in 
the presence of positive reinforcement. It is reported in the 
literature that negative reinforcement impairs the performance 
of chronic schizophrenics. It would be of value to investi-
gate the effects of the simultaneous presentation of negative 
reinforcement and psychoactive drugs. 
Studies with normal subjects report that there is a law-
ful relationship between level of activation and excellence 
of performance. Whether such a relationship is characteristic 
of chronic schizophrenics is not known. The present findings 
suggest that the performance of chronic schizophrenics improves 
in the presence of agents which heighten the level of arousal 
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and is impaired in the presence of agents which lower the level 
of arousal. However, in the absence of physiological indices 
of arousal, such evidence is indirect and merely suggestive. 
For a more direct test of the relationship between arousal and 
performance, chronic schizophrenics should be tested under 
agents known to affect arousal, while physiological measures 
of arousal are concomitantly employed. Such studies would shed 
further light on the hypothesis that in chronic schizophrenics, 
there is a dissociation between behavioral and physiological 
arousal. 
The present findings show that chlorpromazine has a selec-
tive effect on sustained attention; it is not known, however, 
whether this is peculiar to chlorpromazine or is characteristic 
of all the phenothiazines. 
From a comparison of the present findings with those of 
research on normal persons, it appears that the performance of 
chronic schizophrenics is less affected by chlorpromazine than 
is that of normal subjects, but that the performance of the 
two populations is impaired to about the same extent by barbi-
turates. It was suggested that as compared to normals, chronic 
schizophrenics respond to a lesser degree to the peripheral ef-
fects of psychoactive drugs, but that they respond to the same 
degree to the central effects. Further experimentation with 
pharmacological agents which are known to affect primarily the 
central nervous system and agents which do not have such an 
effect would seem like a valuable research effort for the 
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determination of response differences between normals and chronic 
schizophrenics to the effects of drugs. 
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CHAPTER VI. SUMMARY 
The purpose of the present study was to determine whether 
positive reinforcement, chlorpromazine and secobarbital alter 
the ability of chronic schizophrenics to maintain sustained 
attention and whether these affect their psychomotor functioning. 
Neurophysiological and psychological findings indicate 
that the effect of reinforcement is to raise the level of 
activation, and that the effects of chlorpromazine and seco-
barbital are to lower the level of activation. Activation 
theory postulates that there is a lawful relationship between 
the level of activation or arousal and performance, and that 
this relationship is characterized by an inverted U-shaped curve. 
That is, on a given task performance is optimal at a moderate 
level of arousal and impaired at low or high arousal levels. 
It is a further postulate of activation theory that variables 
which affect the level of activation will cause an impairment 
or an improvement in the performance of a given subject depending 
on the subject's pre-experimental level of arousal. That is, 
the performance of a subject in a high state of arousal will 
be impaired if his arousal level is depressed. Conversely, 
if a subject is normally in a state of low arousal, a moderate 
increment in his level of arousal will improve his performance 
and a depression of his arousal level will produce a further 
performance impairment. 
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The literature suggests that chronic schizophrenics are 
characterized by a state of hypoarousal. On the basis of these 
considerations the following general hypotheses were formulated: 
1. Reinforcement improves sustained attention, 
augments psychomotor output, and decreases response 
latency in chronic schizophrenics. 
2. Chlorpromazine and secobarbital impair sus-
tained attention, decrease psychomotor output, and 
increase response latency in chronic schizophrenics. 
3. Relative to secobarbital, the effect of 
chlorpromazine in chronic schizophrenics is more pro-
nounced on sustained attention; less pronounced on 
psychomotor output and response latency. 
4. In the presence of reinforcement the effects 
of these drugs in chronic schizophrenics are reduced. 
The third hypothesis derives from recent findings that chlor-
promazine, as compared to barbiturates, has a selective effect on 
sustained attention in normal persons. 
Eight male, chronic schizophrenic patients, with an age 
range of 25-50 and in good physical health, served as the sub-
jects. All subjects had been hospitalized continuously for at 
least three years. Medication was discontinued for all subjects 
two months before the study started. 
In the course of twelve testing days, each patient had two 
testing days each on chlorpromazine 100 mg, chlorpromazine 200 mg, 
secobarbital 100 mg, secobarbital 200 mg, an inert placebo, and 
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no medication. The patients were rotated through all conditions, 
so that each patient served as his own control. A testing day 
consisted of four sessions: 1/2, 1 1/2, 2 1/2 and 3 1/2 hours 
post-medication. The time interval, thus, between medication 
and testing sessions was also subject to analysis. 
The testing involved repeated administration of the Con-
tinuous Performance Test (CPT) and the Subject-Paced Test (SPT), 
given under conditions of reinforcement and no-reinforcement. 
Candy and cigarettes served as the reinforcers. 
On the CPT, a test of sustained attention, a subject was 
required to respond, by pulling a lever, to one of twelve letters 
which were randomly exposed at the rate of 1.10 sec. for a 
period of .10". In this study the letter x served as the critical 
stimulus, and it appeared on the average every fifth letter. 
The following measures were available from the CPT: a) er-
rors of omission: missed responses to the critical stimulus; 
b) errors of commission: responses to stimuli other than the 
critical stimulus; and c) response latency: the time that 
elapsed between the onset of the critical stimulus and the re-
sponse to it, The errors of omission and commission scores 
served as the indices of sustained attention. 
The SPT was similar to the CPT except that the rate of 
stimulus presentation was controlled by the subject. Pulling 
one of two levers changed the stimuli till the critical stimulus 
appeared and stayed on unless the other lever was pulled. The 
number of total lever pulls served as the index of psychomotor 
output. 
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Two analyses of variance for correlated scores were per-
formed on each dependent variable. 
The first analysis evaluated the effect of placebo, as 
compared to the no-drug condition, as well as the variance as-
sociated with repeating the no-drug and placebo conditions twice. 
The second analysis evaluated the main drug, reinforcement and 
hour effects, as well as the interactions between them. 
The statistical tests of the differences in performance 
under the placebo and no-drug conditions revealed no signifi-
cant differences between the two conditions on any dependent 
variable of the experiment. The scores from the no-drug condi-
tion were, therefore, excluded from further statistical treat-
ment. 
In the case of all the dependent variables, except num-
ber of responses on the SPT, there was no significant differ-
ence in performance between the two periods. In the further 
analyses, therefore, the SPT scores from both periods were 
analyzed separately, while the scores from both periods of the 
other dependent variables were pooled. 
In the presence of reinforcement, performance on all the 
dependent variables except commission errors was significantly 
better than in the absence of reinforcement. In the presence of 
the drugs, performance on all the dependent variables was signi-
ficantly impaired. The effects of the drugs and reinforcement 
were found to be independent. The absolute impairment caused by 
the drugs was reduced when it was present simultaneously with 
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reinforcement. For each drug, the higher dose caused the greater 
impairment. 
The time-response curves of the two drugs were dissimilar: 
the peak effect of secobarbital occurred 1/2 hour after adminis-
tration, while chlorpromazine approached its peak 3 1/2 hours 
after administration. At their peaks, chlorpromazine had a 
greater effect on sustained attention, while secobarbital had 
a greater effect on both response latency and psychomotor output, 
but these differences were not statistically significant. 
It is concluded from the results of the experiment that: 
a) chronic schizophrenics are characterized by a level of acti-
vation below the optimum middle for best performance; b) positive 
reinforcement improves the sustained attention and psychomotor 
performance of chronic schizophrenics; c) chlorpromazine and seco-
barbital impair the sustained attention and psychomotor perform-
ance of chronic schizophrenics; d) the effects of chlorpromazine 
on sustained attention are larger than the secobarbital effects, 
and e) in the presence of reinforcement, the absolute impairment 
caused by chlorpormazine and secobarbital is reduced. 
A comparison of the present findings with studies on normals 
suggests that: a) the effect of secobarbital is similar in both 
populations; b) the effect of chlorpromazine is more pronounced 
in normals; and c) the selective effect of chlorpromazine on sus-
tained attention is present in both populations. Possible 
reasons for the dissimilar effects of these drugs in the two 
populations are discussed. 
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APPENDIX A 
DESCRIPTION OF APPARATUS 
Description of Apparatus 
The apparatus employed was a combination of the operant 
conditioning machine, as used for humans, and the Continuous 
Performance Test (CPT), a test of sustained attention, des-
cribed by Rosvold, et al (1956). A subject was seated 
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before a manipulandum containing two pull-levers, a little 
window for the presentation of visual stimuli and a magazine 
receptacle for reinforcements (Photo A). A dim, small bulb 
illuminated the room which was bare otherwise. During testing, 
a subject was alone in the room, but the experimenter was 
able to observe him through a one-way mirror. In an adjacent 
room were the recording devices, the reinforcement magazine, 
and the machine that scheduled the presentation of stimuli and 
reinforcements. (Photo B). One at a time, twelve letters (A, 
C, E, H, K, L, N, P, S, V, X, Z) were randomly presented in 
the stimulus window at the rate of 1.10 seconds, and were 
exposed for 0.10 seconds. The letter X, the critical stimulus, 
appeared on the average once in every five stimuli. Each 
series consisted of 72 stimuli. The order of the stimuli within 
a series was changed from time to time, thus preventing the 
learning of an order and anticipating the critical stimulus. 
In addition to the two timers which controlled the 
interval between stimuli and the duration of stimulus exposure, 
a third timer activated the reinforcement magazine, during 
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reinforced trials, for a fraction of the time between the 
onset of the X and the next stimulus. If a response occurred 
during this interval, it was reinforced. For each subject 
the time value represented the interval during which 50% of 
his responses to the X occurred under reinforcement and while 
in training. 
The recording devices consisted of: a) four counters 
which recorded the number of total stimuli presented, number 
of critical stimuli presented, number of reinforced responses, 
and total number of responses; b) an Esterlyne-Angus Event 
Recorder which recorded the presentation of the critical 
stimuli, as well as all responses separately and those made 
to the critical stimulus; c) a clock which cumulated over a 
session the actual time that elapsed between the presentation 
of an X and the subject's response. The onset of an X 
activated this clock and a subject's response or the next 
stimulus if the subject did not respond, stopped it. For each 
session, then, it was possible to compute the mean-response 
latency by subtracting from the cumulated-response latency the 
time value of the unresponded-to X's, if such occurred, and 
dividing the remainder by the number of responses to the letter 
x. 
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APPENDIX B 
STATISTICAL MODELS 
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TABLE 1 
Analysis of Variance Model For The Evaluation of 
Placebo and Repeated Testing Effects 
REINFORCED NON -REINFORCED 
TRIALS TRIALS 
df for df for 
.... , ... ,,.. .... , ....... 
Source of Variance df sig. te sf'"'' df sig. test"'''' 
Treatments {Placebo-No Drug) 1 7 1 7 
Periods (1st - 2nd) 1 7 1 7 
Hours 3 21 3 21 
Subjects 7 7 
Treatment X Periods 1 7 1 7 
Treatment X Hours 3 21 3 21 
Hours X Periods 3 21 3 21 
Treat. X Hours X Per. 3 21 3 21 
,,, ,,, 
Error 1 05''' 10 5''' 
The 105 degrees of freedom for error represent the value 
from the pooled interactions which was used for finding the 
error mean square. 
:>!~~:~ The values in this column, rather than the df associated with 
the pooled interactions, were used to enter the F table. 
TABLE 2 
Analysis of Variance Model For The Evaluation of the 
Drugs, Reinforcement and Hour Effects 
df for 
,,,.. ...... 
Source of Variance df Significance tesf'"'' 
Drugs 4-J. 28 
Reinforcement 1 7 
Hours 3# 21 
Subjects 7 
Drugs X Reinforcement 4 28 
Drugs X Hours 12 84 
Reinforcement X Hours 3 21 
Drugs X Rein£. X Hours 12 84 
,,, 
Error 273"'' 
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The 4 degrees of freedom are associated with the 5 drug conditions: 
placebo; 100 mg chlorpromazine; 200 mg chlorpromazine; 100 mg 
secobarbital; 200 mg secobarbital. 
With 4 testing sessions on each test day, 3 df are available for the 
evaluation of hour effect. 
The 273 degrees of freedom for error represent the value from the 
pooled interactions which was used for finding the error mean 
square. 
The values in this column, rather than the df associated with the 
pooled interactions, were used to enter the F table. 
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APPENDIX C 
ANALYSIS OF VARIANCE RESULTS 
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TABLE 1 
Analysis of Variance: Errors of Omission 
Sums of Degrees Mean 
Source Squares of Freedom Square F p 
Drugs 2195 4 549 11. 26 <. 0005 
Reinforcement 698 1 698 14.31 <. 01 
Hours 18 3 6 < 1. 00 
Subjects 9899 7 1414 
Drugs X Reinf. 96 4 24 <1. 00 
Drugs X Hours 2606 12 217 4.45 <. 0005 
Reinf. X Hours 7 3 2.3 < 1. 00 
Drugs X Reinf. X Hours 95 12 8 < 1. 00 
Error 13305 273 49 
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TABLE 2 
Analysis of Variance: Errors of Commission 
Sums of Degrees Mean 
Source Squares of Freedom Square F p 
Drugs 50 4 12.50 4.65 <. 01 
Reinfo r c em en t 40 1 40.25 14.96 < . 01 
Hours 6 3 1. 91 < 1. 00 
Subjects 708 7 101 
Drugs X Rein£. 20 4 5 1. 90 
Drugs X Hours 53 12 4.40 1. 64 
Hours X Rein£. 8 3 2. 73 1. 01 
Drugs X Hours X Rein£.17 12 1. 40 < 1. 00 
Error 736 273 2.70 
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TABLE 3 
Analysis of Variance: Response Latency 
Sums of Degrees Mean 
Source Squares of Freedom Square F p 
Drugs .3762 4 . 0940 20.00 <.0005 
Reinforcement . 2050 1 . 2050 43.62 <.0005 
Hours • 0017 3 • 0006 < 1. 00 
Subjects 8.8689 7 1. 2670 
Drugs X Rein£. . 0082 4 • 0020 < 1. 00 
Drugs X Hours . 4336 12 . 0361 7.68 <. 0005 
Hours X Rein£. . 0004 3 • 0001 < 1. 00 
Drugs X Rein£. X Hours . 0162 12 . 0014 < 1. 00 
Error 1.2846 273 • 0047 
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TABLE 4 
Analysis of Variance: Number Responses (SPT), 1st Period 
Sums of Degrees Mean 
Source Squares of Freedom Square F p 
Drugs 289 4 72 11. 75 <.0005 
Reinforcement 169 1 169 27. 59 <. 0005 
Hours 99 3 33 5.39 
Subjects 2444 7 349 
Drugs X Rein£. 7 4 1.7 < 1. 00 
Drugs X Hours 251 12 21 3.41 <. 0005 
Hours X Rein£. 5 3 1.7 < 1. 00 
Drugs X Hours X Rein£. 13 12 1. 06 < 1. 00 
Error 1676 273 6. 14 
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TABLE 5 
Analysis of Variance: Number Responses (SPT), 2nd Period 
Sums of Degrees Mean 
Source Squares of Freedom Square F p 
Drugs 193 4 48 7. 59 <. 001 
Reinforcement 161 1 161 25.34 <. 0005 
Hours 12 3 4 < 1. 00 
Subjects 3239 7 463 
Drugs X Rein£. 5 4 1. 18 <1. 00 
Drugs X Hours 495 12 41 6.48 <. 0005 
Hours X Rein£. 1. 22 3 . 41 < 1. 00 
Drugs X Hours X Rein£. 8 12 . 64 < 1. 00 
Error 1738 273 6.36 
APPENDIX D 
COMPARISON DATA WITH THE PERFORMANCE 
OF NORMALS ON THE CPT 
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Average Number of Omission Errors Associated 
with Placebo, Chlorpromazine, and Secobarbital 
in Normals and Chronic Schizophrenics 
Mirsky 
PRESENT STUDY Mirsky and 
Reinforced Non-Rein£. et al, f:. Cardon, 
Trials Trials 1959 1962 
Placebo 3.6 5. 9 2. 5 1.0 
CPZ 100 (2 1/2 hr) 7.4 12. 0 9.4 
{CPZ 100 - Placebo) 3.8 6. 1 6. 9 
CPZ 100 (3 1/2 hr) 8. 1 11.8 
(CPZ 100 - Placebo) 4. 5 5. 9 
CPZ 200 (2 1/2 hr) 12.9 17.6 17. 5 
{CPZ 200 - Placebo) 9.3 11. 7 15. 0 
CPZ 200 (3 1/2 hr) 13.4 18.4 29.0 
(CPZ 200 - Placebo) 9.8 12. 5 28. 0 
Seco 200 - (30 1 -50 1 ) 11.8 16.6 13. l>!C 
(Seco 200 - Placebo) 8.2 10. 7 1 o. 6 
-; Both male and female subjects 
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Primae, 
et al, f:. 
1957 
4.4 
1 o. 6 
6. 2 
27. 1 
22.7 
~:~ This is the median score for the group and is the omission error 
associated with the AX task (a response is demanded whenever X 
follows A) which is a more difficult task and produces more 
omission errors than the X task (a response is demanded to X 
regardless of the letter stimulus that precedes it). 
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The purpose of the present study was to determine whether 
positive reinforcement, chlorpromazine and secobarbital alter 
the ability of chronic schizophrenics to maintain sustained 
attention and whether these affect their psychomotor functioning. 
Eight male, chronic schizophrenic patients, with an age 
range of 25-50 and in good physical health, served as the 
subjects. All subjects had been hospitalized continuously 
for at least three years. Medication was discontinued for 
all subjects two months before the study started. In the 
course of the study, each subject was tested twice under all 
of the following conditions: no-drug, placebo, chlorpromazine 
100 mg, chlorpromazine 200 mg, secobarbital 100 mg, secobarbital 
200 mg. The drugs were given once weekly in single doses. 
A testing day consisted of four sessions: 1/2, 1 1/2, 2 1/2, 
and 3 1/2 hours post-medication. The different drug conditions 
were administered according to a modified Latin Square design 
with each active drug following each other active drug an equal 
number of times. Half of the trials in each session were rein-
forced by candy and cigarettes and the other half were not. 
Two tests were employed: The Continuous Performance Test 
(CPT), and the Subject Paced Test (SPT). On the CPT, a test 
of sustained attention, a subject is required to respond, by 
pulling a lever, to one of twelve letters which are randomly 
exposed at the rate of 1.10 sec. for a period of .10 second. 
The following measures were available from the CPT: 
a) errors of omission: missed responses to the critical 
stimulus; b) errors of commission: responses to stimuli 
other than the critical stimulus; and c) response latency: 
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the time that elapsed between the onset of the critical stimulus 
and the response to it. The errors of omission and commission 
scores served as the indices of sustained attention. 
The SPT is similar to the CPT except that the rate of 
stimulus presentation is controlled by the subject. Pulling 
one of two levers changes the stimuli until the critical 
stimulus appears and stays on unless the other lever is pulled. 
The number of total lever pulls served as the index of psycho-
motor output. 
An analysis of variance for correlated data revealed 
that the variances associated with "Drugs", "Reinforcement11 , 
and "Drugs X Hours" were significant for all dependent variables, 
but the "Drug X Reinforcement" interaction was not. In no case 
was placebo different from the no-drug condition. The effect 
of 100 mg of secobarbital was significantly different from 
placebo on response latency only, but the effect of the other 
drug conditions was significant on all three behavioral measures. 
For each drug, the higher dose caused the greater impairment. 
The time-response curves of the two drugs were dissimilar: 
the peak effect of secobarbital occurred 1/2 hour after adminis-
tration, while that of chlorpromazine was 3 1/2 hours after 
administration. At their peaks, chlorpromazine had a greater 
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effect on sustained attention, while secobarbital had a greater 
effect on both response latency and psychomotor output. 
It is concluded from the results of the experiment that: 
1. Reinforcement improves sustained attention, augments 
psychomotor output, and decreases response latency in chronic 
schizophrenics. 
2. Chlorpromazine and secobarbital impair sustained attention, 
decrease psychomotor output and increase response latency in 
chronic schizophrenics. 
3. Relative to secobarbital, the effect of chlorpromazine 
in chronic schizophrenics is more pronounced on sustained 
attention, but not on psychomotor output and response latency. 
4. In the presence of reinforcement the effects of these 
drugs in chronic schizophrenics are reduced. 
A comparison of the present findings with studies on normals 
suggests that: a) the effect of secobarbital is similar in 
both populations; b) the effect of chlorpromazine is more pro-
nounced in normals; and c) the selective effect of chlorproma-
zine on sustained attention is present in both populations. 
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